<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">92168</article-id>
<article-id pub-id-type="doi">10.7554/eLife.92168</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92168.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology and Inflammation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Amphibian mast cells: barriers to chytrid fungus infections</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hauser</surname>
<given-names>Kelsey A</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garvey</surname>
<given-names>Christina N</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crow</surname>
<given-names>Ryley S</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hossainey</surname>
<given-names>Muhammad RH</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Howard</surname>
<given-names>Dustin T</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ranganathan</surname>
<given-names>Netra</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gentry</surname>
<given-names>Lindsey K</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yaparla</surname>
<given-names>Amulya</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalia</surname>
<given-names>Namarta</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zelle</surname>
<given-names>Mira</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Elizabeth J</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duttargi</surname>
<given-names>Anju N</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rollins-Smith</surname>
<given-names>Louise A</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muletz-Wolz</surname>
<given-names>Carly R</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Grayfer</surname>
<given-names>Leon</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Biological Sciences, The George Washington University</institution>, Washington, DC, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Center for Conservation Genomics, Smithsonian National Zoo &amp; Conservation Biology Institute</institution>, Washington, DC, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University</institution>, Washington DC, <country>USA</country></aff>
<aff id="a4"><label>4</label><institution>Departments of Pathology, Microbiology and Immunology, and of Pediatrics, Vanderbilt University School of Medicine</institution>, Nashville, TN, <country>USA</country></aff>
<aff id="a5"><label>5</label><institution>Department of Biological Sciences, Vanderbilt University</institution>, Nashville, TN, <country>USA</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Kim</surname>
<given-names>Brian S</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Rath</surname>
<given-names>Satyajit</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Indian Institute of Science Education and Research (IISER)</institution>
</institution-wrap>
<city>Pune</city>
<country>India</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding author: Suite 6000, 800 22<sup>nd</sup> St NW, Washington, DC 20052, USA. Phone: 202-994-8076, Email: <email>leon_grayfer@gwu.edu</email>.</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-12-19">
<day>19</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2024-07-16">
<day>16</day>
<month>07</month>
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP92168</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-09-12">
<day>12</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-10-01">
<day>01</day>
<month>10</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.29.560127"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2023-12-19">
<day>19</day>
<month>12</month>
<year>2023</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92168.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.92168.1.sa3">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.92168.1.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.92168.1.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.92168.1.sa0">Reviewer #3 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.92168.1.sa4">Author Response:</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Hauser et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hauser et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-92168-v2.pdf"/>
<abstract>
<title>Abstract</title><p>Global amphibian declines are compounded by deadly disease outbreaks caused by the chytrid fungus, <italic>Batrachochytrium dendrobatidis</italic> (<italic>Bd</italic>). Much has been learned about the roles of amphibian skin-produced antimicrobial components and microbiomes in controlling <italic>Bd</italic>, yet almost nothing is known about the roles of skin-resident immune cells in anti-<italic>Bd</italic> defenses. Mammalian mast cells reside within and serve as key immune sentinels in barrier tissues like skin. Accordingly, we investigated the roles of <italic>Xenopus laevis</italic> frog mast cells during <italic>Bd</italic> infections. Our findings indicate that enrichment of <italic>X. laevis</italic> skin mast cells confers significant anti-<italic>Bd</italic> protection and ameliorates the inflammation-associated skin damage caused by <italic>Bd</italic> infection. This includes a significant reduction in <italic>Bd</italic>-infected skin infiltration by neutrophils. Augmenting frog skin mast cells promotes greater mucin content within cutaneous mucus glands and protects frogs from <italic>Bd</italic>-mediated changes to their skin microbiomes. Mammalian mast cells are known for their production of the pleiotropic interleukin-4 (IL4) cytokine and our findings suggest that the frog IL4 plays a key role in conferring the effects seen following frog skin mast cell enrichment. Together, this work underlines the importance of amphibian skin-resident immune cells in anti-<italic>Bd</italic> defenses and illuminates a novel avenue for investigating amphibian host-chytrid pathogen interactions.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>mast cells</kwd>
<kwd>chytrid fungus</kwd>
<kwd>amphibian immunity</kwd>
<kwd>skin immunity</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>This manuscript has been revised to include additional functional data. This includes additional data on the frog skin mast cell and neutrophil content during Bd infections as well as the roles of mast cell-produced interleukin-4 in anti-Bd protection.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Catastrophic declines of hundreds of amphibian species across six continents have been causally linked to the chytrid fungi, <italic>Batrachochytrium dendrobatidis</italic> (<italic>Bd</italic>) and <italic>Batrachochytrium salamandrivorans</italic> (<italic>Bsal</italic>)<sup><xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c2">2</xref></sup>. Motile <italic>Bd</italic> zoospores readily colonize keratinized skin of adult amphibians and keratinized mouthparts of tadpoles<sup><xref ref-type="bibr" rid="c3">3</xref></sup>. <italic>Bd</italic> skin infections culminate in chytridiomycosis, ultimately disrupting the function of this respiratory and barrier tissue<sup><xref ref-type="bibr" rid="c3">3</xref>, <xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c5">5</xref></sup>. Effectively combatting chytrid infections requires a holistic understanding of amphibian cutaneous immune defenses. Research efforts up to this point have focused on antifungal capacities of amphibian skin-produced antimicrobial peptides<sup><xref ref-type="bibr" rid="c6">6</xref>, <xref ref-type="bibr" rid="c7">7</xref></sup>; commensal antifungal products<sup><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c9">9</xref></sup>; antifungal properties of mucus<sup><xref ref-type="bibr" rid="c9">9</xref></sup>, alkaloids<sup><xref ref-type="bibr" rid="c10">10</xref></sup>, and lysozymes<sup><xref ref-type="bibr" rid="c11">11</xref>, <xref ref-type="bibr" rid="c12">12</xref></sup> as well as the roles of antibodies<sup><xref ref-type="bibr" rid="c4">4</xref>,<xref ref-type="bibr" rid="c13">13</xref></sup>. Many of these studies suggest that <italic>Bd</italic> exposure can elicit some immune protection<sup><xref ref-type="bibr" rid="c14">14</xref></sup>. However, the contribution of skin-resident immune cells to amphibian anti-<italic>Bd</italic> defenses remains almost entirely unexplored.</p>
<p>Mammalian mast cells serve as sentinels of mucosal and connective tissues, including in barrier tissues like skin, where they maintain homeostasis and regulate immune responses<sup><xref ref-type="bibr" rid="c15">15</xref></sup>. Other granulocyte-lineage cells such as neutrophils are generally not found in healthy tissues and only extravasate into sites of inflammation<sup><xref ref-type="bibr" rid="c16">16</xref></sup>. Consequently, mast cells are among the first immune cells to recognize and respond to skin-infiltrating pathogens. When activated, mast cells release pre-formed and <italic>de novo</italic>-generated immunomodulatory compounds that may serve to elicit, exacerbate, or ameliorate inflammatory responses<sup><xref ref-type="bibr" rid="c15">15</xref></sup>. One of these mast cell-produced mediators, the interleukin-4 (IL4) cytokine dampens inflammation and promotes tissue repair<sup><xref ref-type="bibr" rid="c17">17</xref></sup>. Cells bearing hallmark mast cell cytology have been reported across a range of non-mammalian species<sup><xref ref-type="bibr" rid="c18">18</xref>, <xref ref-type="bibr" rid="c19">19</xref></sup>, including amphibians<sup><xref ref-type="bibr" rid="c20">20</xref></sup>. Notably, the principal mast cell growth factor, stem cell factor (SCF, KIT ligand) required for mast cell differentiation and survival<sup><xref ref-type="bibr" rid="c21">21</xref></sup> is expressed by all vertebrates examined to-date.</p>
<p>Here, we combine comprehensive <italic>in vitro</italic> and <italic>in vivo</italic> approaches to define the roles of amphibian (<italic>Xenopus laevis</italic>) mast cells during <italic>Bd</italic> infections. Our results provide compelling evidence that skin-resident immune cells contribute to anti-<italic>Bd</italic> defenses.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Frog mast cells possess archetypal mast cell cytology and transcriptional profiles</title>
<p>We produced <italic>X. laevis</italic> recombinant (r)SCF, and used this reagent to generate mast cell cultures from bone marrow-derived myeloid precursors<sup><xref ref-type="bibr" rid="c22">22</xref></sup>. Mast cells were compared to bone marrow-derived neutrophilic granulocytes (hereafter referred to as ‘neutrophils’), differentiated using a recombinant <italic>X. laevis</italic> colony-stimulating factor-3<sup><xref ref-type="bibr" rid="c22">22</xref></sup> (rCSF3, <italic>i.e</italic>., granulocyte colony-stimulating factor; GCSF). While the neutrophil cultures were comprised of cells with hyper-segmented nuclei and neutral-staining cytoplasms (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>), the mast cell cultures consisted predominantly of mononuclear cells with basophilic cytoplasm (<xref rid="fig1" ref-type="fig">Fig. 1B</xref>). We confirmed the granulocyte-lineage of <italic>X. laevis</italic> mast cells using specific esterase (SE) staining (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>). As expected, <italic>X. laevis</italic> neutrophils were also SE-positive (<xref rid="fig1" ref-type="fig">Fig. 1C</xref>). Mast cell and neutrophil morphology was further explored with electron microscopy (<xref rid="fig1" ref-type="fig">Fig. 1E-H</xref>). SEM imaging demonstrated that <italic>X. laevis</italic> mast cells possess extensive folding of their plasma membranes (<xref rid="fig1" ref-type="fig">Fig. 1F</xref>). This mast cell-characteristic membrane ruffling appeared as projections resembling pseudopods via TEM, which further revealed electron-dense heterogenous granules, few mitochondria, and round to elongated nuclei (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>) typical of mammalian mast cells<sup><xref ref-type="bibr" rid="c23">23</xref></sup>. <italic>X. laevis</italic> neutrophils also exhibited pronounced membrane ruffling (<xref rid="fig1" ref-type="fig">Fig. 1E</xref>) but strikingly distinct intracellular appearance including multilobed nuclei (<xref rid="fig1" ref-type="fig">Fig. 1G</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title><italic>X. laevis</italic> bone marrow-derived mast cells possess classical mast cell cytology and transcriptional profiles.</title>
<p>Neutrophils (<bold>A</bold>, <bold>C</bold>, <bold>E</bold>, <bold>G</bold>) and mast cells (<bold>B</bold>, <bold>D</bold>, <bold>F</bold>, <bold>H</bold>) were stained with Giemsa (<bold>A</bold>, <bold>B</bold>) and Leder to visualize specific esterase activity (SE) (<bold>C</bold>, <bold>D</bold>) or imaged with scanning and transmission electron microscopy (SEM: <bold>E</bold>, <bold>F</bold> and TEM: <bold>G</bold>, <bold>H</bold>). (<bold>I</bold>) Heat map of the top 30 differentially expressed genes (DEGs) identified with RNA sequencing analyses of <italic>X. laevis</italic> mast cell (<italic>N</italic>=4) and neutrophil (<italic>N</italic>=4) cultures. Log<sub>2</sub>fold change in expression represented as color scale.</p></caption>
<graphic xlink:href="560127v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Frog mast cells and neutrophils exhibited distinct transcriptional profiles of immune-related genes including those encoding lineage-specific transcription factors, immune receptors, downstream signaling components and adhesion molecules, as well as non-immune genes (<xref rid="fig1" ref-type="fig">Fig. 1I</xref>). Frog mast cells and neutrophils each expressed greater levels of lineage-specific transcription factors associated with mammalian mast cell (gata1, gata2, and mitf)<sup><xref ref-type="bibr" rid="c24">24</xref></sup> and neutrophil (cebp family members)<sup><xref ref-type="bibr" rid="c25">25</xref></sup> counterparts, respectively (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). Notably, mast cells expressed greater levels of enzyme and cytokine genes associated with tissue remodeling (carboxypeptidase-3; cpa3<sup><xref ref-type="bibr" rid="c26">26</xref></sup>), immune suppression (indoleamine 2,3 dioxygenase-1; ido1<sup><xref ref-type="bibr" rid="c27">27</xref></sup>) and amelioration of cutaneous inflammation (leukemia inhibitory factor, lif<sup><xref ref-type="bibr" rid="c28">28</xref></sup>; <xref rid="fig2" ref-type="fig">Fig. 2B</xref>). Conversely, neutrophils expressed predominantly proinflammatory enzymes and cytokine genes such as leukotriene 4 hydrolase (lta4h; <xref rid="fig2" ref-type="fig">Fig. 2B</xref>) and tumor necrosis factor alpha (tnfa, <xref rid="fig2" ref-type="fig">Fig. 2B</xref>). In addition, mast cells and neutrophils each had greater expression of genes encoding their respective growth factor receptors, kit and csf3r (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Frog mast cells and neutrophils possess gene profiles similar to their mammalian counterparts.</title>
<p>The differentially expressed genes from the RNA sequencing analyses of <italic>X. laevis</italic> mast cells and neutrophil cultures were profiled for those encoding (<bold>A</bold>) transcription factors associated with mast cell- or neutrophil-specific lineages and (<bold>B</bold>) granulocyte antimicrobial components and growth factor receptor genes. <italic>All depicted genes were significantly differentially expressed between the two populations, N</italic>=4 per group.</p></caption>
<graphic xlink:href="560127v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Enriching mast cells in frog skin offers protection against <italic>Bd</italic></title>
<p>Although all granulocyte-lineage cells possess SE activity, mast cells are the predominant mononuclear granulocytes to reside in vertebrate tissues<sup><xref ref-type="bibr" rid="c29">29</xref></sup>. Therefore, we selectively enriched mast cells in <italic>X. laevis</italic> skin via subcutaneous rSCF administration (note SE-stained cells indicated by arrows in r-ctrl-injected skins, <xref rid="fig3" ref-type="fig">Fig. 3A</xref>, versus r-SCF-injected skins, <xref rid="fig3" ref-type="fig">Fig 3B</xref>). We confirmed SE-positive cells in rSCF-treated skins also possessed round-oval nuclei (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>). Maximum mast cell enrichment was observed 12 hours post injection (hpi) of rSCF (<xref rid="fig3" ref-type="fig">Fig. 3D</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure. 3.</label>
<caption><title>Enriching frog cutaneous mast cells lowers <italic>Bd</italic> loads.</title>
<p>Representative images of SE stained (<bold>A</bold>) control and (<bold>B</bold>) mast cell-enriched skin 12 hpi. (<bold>C</bold>) We confirmed the enriched population was composed of mono-morphonuclear cells. (<bold>D</bold>) Mast cell enrichment was optimized across several time points by quantifying SE-positive cells per field of view under 40x magnification. Results represent means ± SEM from 3 animals per time point (2 experimental repeats). (<bold>E</bold>) Mast cell-enriched and control dorsal skins were collected from <italic>X. laevis</italic> 10- and 21-dpi. <italic>Bd</italic> loads are represented as the number of zoospore genomic equivalents (GE) × 10<sup>5</sup> per μl of total input DNA. Time points were analyzed independently. Results represent means ± SEM from 7 animals per experimental group (<italic>N</italic>=7). Asterisks indicate significance: <italic>p</italic> &lt; 0.05 by (<bold>D</bold>) one-way ANOVA with Tukey post-hoc analysis or (<bold>E</bold>) Student’s t-test.</p></caption>
<graphic xlink:href="560127v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We next examined the consequences of enriching frog skin mast cells on <italic>Batrachochytrium dendrobatidis</italic> (<italic>Bd</italic>) infection outcomes. To this end, <italic>X. laevis</italic> were subcutaneously administered with rSCF or the r-ctrl, infected with <italic>Bd,</italic> and the skin fungal loads assessed at 10- and 21-days post infection (dpi). At 10 dpi, skin mast cell-enriched <italic>X. laevis</italic> possessed significantly lower <italic>Bd</italic> loads than r-ctrl administered animals (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>). By 21 dpi, both r-ctrl and rSCF-administered groups possessed substantially greater <italic>Bd</italic> loads, although the mast cell-enriched animals continued to show significantly lower skin fungal loads (<xref rid="fig3" ref-type="fig">Fig. 3E</xref>).</p>
<p>Mammalian mast cells may be labeled <italic>in situ</italic> by using avidin to visualize the heparin-containing mast cell granules<sup><xref ref-type="bibr" rid="c30">30</xref></sup>. Using this approach, we confirmed that frog bone marrow-derived mast cells likewise possess heparin-containing granules (<xref rid="fig4" ref-type="fig">Fig. 4A</xref>&amp;B). We next used this staining approach to visualize and enumerate mast cells in the skins of control, mast cell-enriched and <italic>Bd</italic>-challenged animals (<xref rid="fig4" ref-type="fig">Fig. 4C-I</xref>). We observed that frog skin mast cell enrichment progressively waned with time in mock-infected animals, and by 21 days post mock infection these animals had skin mast cell numbers comparable to r-ctrl-injected, mock-infected control animals (<xref rid="fig4" ref-type="fig">Fig. 4C, D</xref>). Conversely, compared to mock-infected control animals, the rSCF-injected, <italic>Bd</italic>-challenged frogs maintained significantly greater mast cell numbers in their skin throughout the 21-day infection study (<xref rid="fig4" ref-type="fig">Fig. 4C, E-H</xref>). Interestingly, r-ctrl-injected, <italic>Bd</italic>-infected animals exhibited significantly increased skin mast cell numbers at 10- and 21-days of infection, compared to uninfected control frogs (<xref rid="fig4" ref-type="fig">Fig. 4C, I</xref>). Most of these mast cells were observed in the epidermal layer, spreading out between the skin epithelial cells (<xref rid="fig4" ref-type="fig">Fig. 4G</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure. 4.</label>
<caption><title>Heparin content and skin localization of frog mast cells.</title>
<p>Frogs were administered r-ctrl or rSCF subcutaneously, mock or <italic>Bd</italic>-challenged and skin examined after 1, 3, 10 and 21 dpi. (<bold>A, B</bold>) Representative images (cultures derived from 5 individual frogs) of bone marrow-derived frog mast cells, stained with fluorescently labeled avidin to visualize the heparin-containing mast cells (avidin: red; nuclei: blue; actin: green). (<bold>C-I</bold>) Skin tissue from control (r-ctrl) or mast cell-enriched (rSCF), mock-(not shown) and <italic>Bd</italic>-infected (<bold>D-I</bold>) <italic>X. laevis</italic> were stained with fluorescently labeled avidin to visualize mast cells therein (<italic>N</italic>=6 animals per treatment group). Images were inverted in ImageJ for greater contrast and visibility. (<bold>C</bold>) Heparin-containing mast cells were enumerated and depicted as means <underline>+</underline> SEM of heparin-positive cells per field of view, <italic>N</italic>=6 animals per treatment group. Asterisks indicate statistical significance from r-ctrl: <italic>p</italic> &lt; 0.05. Representative images of heparin-containing mast cells in the skins of (<bold>D</bold>) r-ctrl animals 1 dpi; (<bold>E</bold>) rSCF-administered frogs 1 dpi; (<bold>F, G</bold>) rSCF-administered frogs 10 dpi; (<bold>H</bold>) rSCF-administered frogs 21 dpi and (<bold>I</bold>) r-ctrl-treated animals 21 dpi with <italic>Bd</italic>.</p></caption>
<graphic xlink:href="560127v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2c">
<title>Mast cells protect frogs from <italic>Bd</italic>-elicited inflammation-associated pathology</title>
<p>To explore potential mechanisms of mast cell-mediated protection against <italic>Bd,</italic> we compared the gene expression profiles of r-ctrl- and rSCF-administered, <italic>Bd</italic>-infected frog skins at 21 dpi. Among the top differentially expressed genes, we noted mast cell-enriched, <italic>Bd</italic>-infected skins possessed greater transcripts for genes associated with cutaneous strength and integrity (lamc2)<sup><xref ref-type="bibr" rid="c31">31</xref></sup>, suppression of cell migration (b3gnt3.1)<sup><xref ref-type="bibr" rid="c32">32</xref></sup>, as well as ion and nutrient flow (gjb3l)<sup><xref ref-type="bibr" rid="c33">33</xref></sup> (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>). Moreover, mast cell-enriched <italic>Bd</italic>-challenged skin exhibited greater expression of genes associated with protection of the mucosa and epithelial healing (ttf3.6s)<sup><xref ref-type="bibr" rid="c34">34</xref></sup> and mucus production (duoxa1.s<sup><xref ref-type="bibr" rid="c35">35</xref></sup>, gabrp<sup><xref ref-type="bibr" rid="c36">36</xref></sup>; <xref rid="fig5" ref-type="fig">Fig. 5A</xref>). In striking contrast, skins from control <italic>Bd</italic>-infected frogs revealed greater expression of genes associated with leukocyte infiltration and inflammation (<italic>e.g.</italic>, ccl19, cxcl16, adamts13, csf3r; <xref rid="fig5" ref-type="fig">Fig. 5A</xref>). These transcriptional profiles were supported by our histological observations wherein control <italic>Bd</italic>-infected skins exhibited hyperkeratosis, epidermal hyperplasia, jagged stratum corneum, and extensive leukocyte infiltration (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>), while mast cell-enriched <italic>Bd</italic>-infected tissues appeared considerably less afflicted by these pathologies (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>). Quantification of <italic>Bd</italic>-infected skin epidermal thickness confirmed that mast cell-enriched animals possessed significantly less thickened epidermal skin compared to control (r-ctrl), <italic>Bd</italic>-infected animals (<xref rid="fig5" ref-type="fig">Fig. 5D</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure. 5.</label>
<caption><title>Consequences of cutaneous mast cell enrichment.</title>
<p>(<bold>A</bold>) RNAseq analysis of skin tissue from control (r-ctrl) or mast cell-enriched (rSCF) <italic>Bd</italic>-infected <italic>X. laevis</italic> at 21 dpi. Heat map of the top 30 DEGs, numbers matched to colors represent log<sup><xref ref-type="bibr" rid="c2">2</xref></sup> fold change in expression, <italic>N</italic> = 4 r-ctrl-treated, <italic>Bd</italic>-infected and 4 rSCF-treated, <italic>Bd</italic>-infected skin samples. (<bold>B</bold> &amp; <bold>C</bold>) Representative images of control and mast cell-enriched, <italic>Bd</italic>-infected skins, 21 dpi, demonstrating differences in epidermal thickening and mucus gland filling. Mucin content was visualized in cutaneous mucus glands with Alcian Blue/PAS stain. Mucus glands are denoted by ‘m’, and epithelia are denoted by ‘Ep’. ImageJ software was used to determine the means <underline>+</underline> SEM of (<bold>D</bold>) skin epithelial thickness and (<bold>E</bold>) percent mucus gland filling (<italic>N</italic>=6). Asterisks indicate significance: <italic>p</italic> &lt; 0.05 by one-way ANOVA with Tukey post-hoc analysis.</p></caption>
<graphic xlink:href="560127v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Because mast cell-enriched frog skins had greater expression of genes associated with mucosal tissue integrity and mucus production (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>), we also investigated whether the anti-<italic>Bd</italic> protection identified in mast cell-enriched skins could be due, at least in part, to differences in mucus production. Interestingly, the skin mucus glands of mast cell-enriched, mock- and <italic>Bd</italic>-infected frogs were significantly more filled than those of mock- and <italic>Bd</italic>-infected control animals (<xref rid="fig5" ref-type="fig">Fig. 5B,C,E</xref>).</p>
</sec>
<sec id="s2d">
<title>Cutaneous neutrophil enrichment results in increased <italic>Bd</italic> fungal loads</title>
<p>Neutrophils are one of the first leukocytes to infiltrate infected tissues, typically amplifying inflammation<sup><xref ref-type="bibr" rid="c37">37</xref></sup>. All vertebrate neutrophils depend on CSF3 for their differentiation and function<sup><xref ref-type="bibr" rid="c38">38</xref></sup>, and our previous work has demonstrated the gene encoding the CSF3 receptor (csf3r) is a marker of <italic>X. laevis</italic> neutrophils<sup><xref ref-type="bibr" rid="c39">39</xref>, <xref ref-type="bibr" rid="c40">40</xref></sup>. Because csf3r expression was markedly elevated in control over mast cell-enriched skins of infected frogs (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>), we examined the neutrophil content in the skins of these animals over the 21-day course of <italic>Bd</italic> infection (<xref rid="fig6" ref-type="fig">Fig. 6A-E</xref>). To this end, we used <italic>in situ</italic> hybridization analysis of skin-myeloperoxidase, a marker of neutrophils<sup><xref ref-type="bibr" rid="c41">41</xref></sup>. While the skins of r-ctrl- and rSCF-administered, mock-infected frogs contained relatively few neutrophils (<xref rid="fig6" ref-type="fig">Fig. 6A, E</xref>), the skins of r-ctrl-injected, <italic>Bd</italic>-infected animals had significantly elevated neutrophil numbers (<xref rid="fig6" ref-type="fig">Fig. 6B,C,E</xref>). Conversely, at both examined timepoints (10, 21 dpi), mast cell-enriched frog skins possessed neutrophil levels similar to those seen in the uninfected animals (<xref rid="fig6" ref-type="fig">Fig. 6D,E</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Consequences of cutaneous neutrophil enrichment.</title>
<p>(<bold>A-E</bold>) Frogs were administered with r-ctrl or rSCF, mock- or <italic>Bd</italic>-infected and examined <italic>in situ</italic> for neutrophil content via by RNAScope analyses of myeloperoxidase (mpo) transcripts. Representative images of (<bold>A</bold>) r-ctrl-injected frog skins 10 days post mock infection; (<bold>B</bold>) r-ctrl-injected frog skins 10 days post <italic>Bd</italic> infection; (<bold>C</bold>) r-ctrl-injected frog skins 21 days post <italic>Bd</italic> infection; and (<bold>D</bold>) r-SCF-administered frog skins 21 days post <italic>Bd</italic> infection. (<bold>E</bold>) Means <underline>+</underline> SEM of mpo-positive neutrophils per field of view of r-ctrl- and rSCF-administered, mock- or <italic>Bd</italic>-challenged frog skins 10 or 21 dpi, (<italic>N</italic>=6). Asterisks indicate significance from control: <italic>p</italic> &lt; 0.05 by one-way ANOVA with Tukey post-hoc analysis. Representative specific-esterase staining of skin tissues from frogs were administered with (<bold>F</bold>) r-ctrl or (<bold>G</bold>) rCSF3, <italic>N</italic>=4. Arrows denote specific esterase-positive cells. Ep: epithelium. (<bold>H</bold>) <italic>Bd</italic> loads in control and neutrophil-enriched skin tissues 7 dpi, <italic>N</italic>=6. Asterisks indicate significance: p &lt; 0.05 by one-way ANOVA with Tukey post-hoc analysis.</p></caption>
<graphic xlink:href="560127v2_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We next assessed the consequence of enriching frog skins for neutrophils via subcutaneous rCSF3 administration. We confirmed neutrophil enrichment peaked 12 hp rCSF3 injection (<xref rid="figs1" ref-type="fig">Fig. S1</xref>) and resulted in a thickened epidermis in comparison with r-ctrl injected skins of otherwise healthy animals (<italic>i.e.</italic>, no <italic>Bd</italic>; <xref rid="fig6" ref-type="fig">Fig. 6F, G</xref>). When challenged with <italic>Bd</italic>, frogs with neutrophil-enriched skin possessed significantly greater <italic>Bd</italic> loads than control frogs (<xref rid="fig6" ref-type="fig">Fig. 6H</xref>). This suggests that neutrophil-mediated inflammation may be exacerbating <italic>Bd</italic> infections.</p>
</sec>
<sec id="s2e">
<title>Enrichment of frog skin mast cells alters skin microbial composition</title>
<p>Amphibian skin-produced mucus may offer antimicrobial protection and serve as a selective substratum for commensal microbes, many of which are antifungal<sup><xref ref-type="bibr" rid="c9">9</xref></sup>. We found no significant differences in direct <italic>Bd</italic>-killing capacities of mucus isolated from mock- or <italic>Bd</italic>-challenged control or mast cell-enriched frogs (<xref rid="figs2" ref-type="fig">Fig. S2</xref>). By contrast, we observed substantial differences in skin microbiomes, including changes in bacterial composition and richness as well as relative abundances of <italic>Bd</italic>-inhibitory bacteria (<xref rid="fig7" ref-type="fig">Fig. 7</xref>, <xref rid="figs3" ref-type="fig">Fig. S3</xref>). A total of 1645 bacterial amplicon sequence variants (ASVs) were identified from 20 bacterial phyla, seven of which were predominant (<xref rid="fig7" ref-type="fig">Fig. 7A</xref>). Of these, <italic>Verrucomicrobiota</italic> were only present on uninfected animals, whereas <italic>Acidobacteriota</italic> was only seen after 21 dpi on both control and mast cell-enriched, infected animals (<xref rid="fig7" ref-type="fig">Fig. 7A</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Cutaneous mast cells protect skin microbial communities.</title>
<p>Control (r-ctrl-injected) or mast cell-enriched (rSCF-injected) <italic>X. laevis</italic> were mock-infected or challenged with <italic>Bd</italic> for 21 days. (<bold>A</bold>) Microbial phyla distribution across groups. Low abundance phyla (&lt; 5% relative abundance are not shown). At 10 dpi (<bold>B</bold>) community composition (Jaccard distances shown with 80% confidence ellipses) differed among all treatments. (<bold>C</bold>) Relative abundance of <italic>Bd</italic>-inhibitory bacteria and (<bold>D</bold>) bacterial richness were examined in control and mast cell enriched frogs, 10 days post <italic>Bd</italic> or mock challenge. Letters above bars indicate statistically different groups.</p></caption>
<graphic xlink:href="560127v2_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>At 10 dpi, mast cell-enrichment resulted in a nominal shift in community composition compared to control frogs (<xref rid="fig7" ref-type="fig">Fig. 7B</xref>). Notably, while control, <italic>Bd</italic>-infected animals exhibited a drastic shift in community composition, mast cell-enriched animals possessed substantially less deviated community composition (<xref rid="fig7" ref-type="fig">Fig. 7B</xref>), suggesting that these cells are somehow counteracting the adverse effects of <italic>Bd</italic> on microbiome structure. These mast cell-mediated effects persisted to 21 dpi (<xref rid="figs3" ref-type="fig">Fig. S3A</xref>).</p>
<p>At 10 dpi, mast cell-enriched and mock-infected frogs possessed significantly greater abundance of <italic>Bd</italic>-inhibitory bacteria such as <italic>Chyrseobacterium sp</italic>., compared to control, mock infected animals (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>)<sup><xref ref-type="bibr" rid="c42">42</xref></sup>. This suggests that mast cells may promote skin flora composition that is more antifungal. Control (non-enriched) <italic>Bd</italic>-infected frogs possessed significantly greater abundance of <italic>Bd</italic>-inhibitory bacteria than all other treatment groups (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>). While mast cell-enriched, <italic>Bd</italic>-infected frogs had lower abundance of <italic>Bd</italic>-inhibitory bacteria than control infected frogs, they possessed higher abundance of inhibitory taxa than uninfected control animals (<xref rid="fig7" ref-type="fig">Fig. 7C</xref>). The <italic>Bd</italic>-inhibitory bacteria seen in greater abundance on mast cell-enriched, <italic>Bd</italic>-infected animals, included <italic>Roseateles sp</italic>., <italic>Flavobacterium sp.</italic>, and <italic>Kaistia sp</italic>. We did not see significant differences in <italic>Bd</italic>-inhibitory bacteria across the treatment groups at 21 dpi (<xref rid="figs3" ref-type="fig">Fig. S3B</xref>).</p>
<p>Mast cell-enriched uninfected frogs exhibited increased frog skin bacterial richness at 10 dpi (<xref rid="fig7" ref-type="fig">Fig. 7D</xref>). While control <italic>Bd</italic>-infected animals exhibited significantly reduced skin microbial richness, mast cell-enriched <italic>Bd</italic>-infected frogs did not exhibit such a reduction in bacterial richness (<xref rid="fig7" ref-type="fig">Fig. 7D</xref>), supporting the idea that mast cells may be counteracting the adverse effects of <italic>Bd</italic> on skin microbiome composition.</p>
</sec>
<sec id="s2f">
<title>Frog mast cells alter skin antimicrobial peptide gene expression</title>
<p>Amphibians rely heavily on skin-produced antimicrobial peptides (AMPs) for antifungal protection<sup><xref ref-type="bibr" rid="c43">43</xref></sup>, and mast cells produce antimicrobial AMPs<sup><xref ref-type="bibr" rid="c44">44</xref></sup>. We thus examined whether mast cells could be sources of such AMPs during <italic>Bd</italic> infections. As anticipated, <italic>Bd</italic>-challenged mast cells, but not <italic>Bd</italic>-challenged neutrophils upregulated their expression of the AMP-encoding genes, <italic>pgla</italic> and magainin (<italic>mag</italic>, <xref rid="fig8" ref-type="fig">Fig. 8A</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>The roles of IL4 in mast cell-mediated skin anti-<italic>Bd</italic> protection.</title>
<p>(<bold>A</bold>) Mast cells and neutrophils derived from bone marrow of 6 individual frogs (<italic>N</italic>=6) were co-cultured with <italic>Bd</italic> (5 fungal cells per granulocyte) for 6 hrs prior to gene expression analyses of the antimicrobial peptide genes PGLa (<italic>pgla</italic>) and magainin (<italic>mag</italic>) or interleukin-4 (<italic>il4</italic>). (<bold>B</bold>) <italic>Il4</italic> gene expression in skins of control and mast cell-enriched, mock- or <italic>Bd</italic>-infected animals, <italic>N</italic>=6. Representative images of frogs administered with (<bold>C</bold>) r-ctrl or (<bold>D</bold>) rIL4 and infected with <italic>Bd</italic> for 21 days, <italic>N</italic>=7. Ep: epidermis; m: mucus gland. Means <underline>+</underline> SEM of (<bold>E</bold>) percent mucus gland filling, (<bold>F</bold>) skin <italic>Bd</italic> loads, (<bold>G</bold>) epidermal thickness and (<bold>H</bold>) mpo-positive neutrophils, per field of view of r-ctrl- and rSCF-administered, mock- or <italic>Bd</italic>-challenged frog skins 21 dpi, (<italic>N</italic>=7). Representative images of mpo-positive neutrophils in (<bold>I</bold>) control and (<bold>J</bold>) rIL4-treated frog skins, 21 dpi. Ep: epidermis; arrows: mpo-positive neutrophils. Asterisks indicate significance: p &lt; 0.05 by one-way ANOVA with Tukey post-hoc analysis.</p></caption>
<graphic xlink:href="560127v2_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To follow up these observations <italic>in vivo</italic>, we examined <italic>pgla</italic> and <italic>mag</italic> gene expression in the skins of mast cell-enriched and <italic>Bd</italic>-challenged animals. Compared to control (r-ctrl) animals, mast cell-enriched frogs did not have elevated mRNA levels of <italic>mag</italic> or <italic>pgla</italic> after 12 hrs of rSCF administration (<xref rid="figs4" ref-type="fig">Fig. S4A&amp;B</xref>). After 10 days of mock-infection, mast cell-enriched animals possessed significantly greater skin expression of <italic>mag</italic> and <italic>pgla</italic> than control animals (<xref rid="figs4" ref-type="fig">Fig. S4A&amp;B</xref>). We did not see significant differences in skin <italic>mag</italic> or <italic>pgla</italic> gene expression between <italic>Bd</italic>-challenged control and mast cell-enriched frogs after 10 dpi (<xref rid="figs4" ref-type="fig">Fig. S4</xref>). By 21 days of challenge, the rSCF-administered mock-infected frogs possessed lower gene expression levels of both AMPs (significantly so for <italic>pgla</italic>, <xref rid="figs4" ref-type="fig">Fig. S4A&amp;B</xref>), possibly due to some sort of compensatory effect. At 21 dpi, mast cell-enriched frog skins had greater (albeit not significantly so) <italic>pgla</italic> expression than control frogs (<xref rid="figs4" ref-type="fig">Fig. S4B</xref>).</p>
</sec>
<sec id="s2g">
<title>Frog mast cell-expressed interleukin-4 confers anti-<italic>Bd</italic> protection</title>
<p>Mammalian mast cells are recognized as potent producers of the pleotropic anti-inflammatory cytokine, interleukin-4 (<italic>il4</italic>)<sup><xref ref-type="bibr" rid="c45">45</xref></sup>. Notably, <italic>X. laevis</italic> mast cells challenged <italic>in vitro</italic> with <italic>Bd</italic> significantly upregulated their <italic>il4</italic> gene expression, whereas almost no <italic>il4</italic> expression was detected from either unstimulated or <italic>Bd</italic>-challenged neutrophils (<xref rid="fig8" ref-type="fig">Fig. 8A</xref>).</p>
<p>When we examined the expression of <italic>il4</italic> in the skin of control and mast cell-enriched animals, we found that 12 hours following rSCF administration (time of <italic>Bd</italic> challenge), the mast cell enriched frog skins possessed significantly greater transcripts of <italic>il4</italic> than control animals (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). By 10 and 21 dpi, both control and mast cell-enriched mock-infected animals possessed baseline skin il4 expression (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). At 10 days of <italic>Bd</italic> infection, control animals possessed increased (not significantly) skin <italic>il4</italic> gene expression whereas mast cell-enriched frog skins had significantly elevated <italic>il4</italic> transcript levels (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>). By 21 dpi, <italic>Bd</italic>-infected control animals had baseline skin <italic>il4</italic> expression and the mast cell enriched animals had elevated, albeit not significant expression of this cytokine gene in their skins (<xref rid="fig8" ref-type="fig">Fig. 8B</xref>).</p>
<p>To examine whether IL4 could confer the anti-<italic>Bd</italic> effects seen following frog skin mast cell enrichment, we produced this <italic>X. laevis</italic> cytokine in recombinant form (rIL4) and confirmed that subcutaneous injection of rIL4 augmented expression of genes typically activated by the mammalian IL4<sup><xref ref-type="bibr" rid="c46">46</xref></sup> (cd36, metalloproteinase inhibitor 3-timp3, and monoamine oxidase A-maoa; <xref rid="figs5" ref-type="fig">Fig. S5A</xref>).</p>
<p>We next administered frogs subcutaneously with rIL4 or r-ctrl, challenged them with <italic>Bd</italic> and examined the key parameters affected by skin mast cell<italic>-</italic>enrichment, including skin mucus gland filling, skin <italic>Bd</italic> loads, and reduction in <italic>Bd</italic>-associated skin inflammation. When we examined the mucus content of control and rIL4-administered animals, we found that frogs treated with rIL4 possessed greater skin mucus gland filling than control animals and irrespective of mock- or <italic>Bd</italic>-challenge (<xref rid="fig8" ref-type="fig">Fig. 8C-E</xref>). At 21 dpi (but not at 10 dpi), rIL4-administered frogs possessed significantly lower skin <italic>Bd</italic> loads (<xref rid="fig8" ref-type="fig">Fig. 8F</xref>) and exhibited significantly less epidermal thickening (<xref rid="fig8" ref-type="fig">Fig. 8C,D,G</xref>) and less neutrophil infiltration (<xref rid="fig8" ref-type="fig">Fig. 8H-J</xref>) than control animals. Conversely, subcutaneous administration of rIL4 to animals with active <italic>Bd</italic>-infection did not alter their fungal loads (<xref rid="figs5" ref-type="fig">Fig. S5B</xref>), suggesting a critical point during which IL4 may offer protection against this fungal pathogen.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Amphibian extinction rates far outpace those of any other vertebrate class<sup><xref ref-type="bibr" rid="c47">47</xref></sup>. It is now well-established that chytrid fungi are major contributors to these declines, and strikingly, are considered the greatest infectious disease threat to biodivsersity<sup><xref ref-type="bibr" rid="c48">48</xref></sup>. The development of effective mitigation strategies though, is hindered by incomplete understanding of amphibian immune defenses and skin integrity. In this respect, while mast cells are recognized as key immune sentinels of tissues such as skin<sup><xref ref-type="bibr" rid="c49">49</xref></sup>, relatively little is known about this cell lineage outside of mammals. Our findings provide the first in-depth functional analyses of these cells in amphibians and explore their protective mechanisms during chytrid infections. This work presents a unique perspective on the evolution of mast cell functionality and will serve as a new avenue to explore ways to counteract the amphibian declines.</p>
<p>Mammalian mast cells are potent producers of the pleotropic anti-inflammatory interleukin-4 (IL4)<sup><xref ref-type="bibr" rid="c45">45</xref></sup> cytokine and our findings suggest that this is also true of frog mast cells. In mammals, IL4 also plays roles in tissue repair<sup><xref ref-type="bibr" rid="c17">17</xref></sup> and mucus production by intestinal goblet cells<sup><xref ref-type="bibr" rid="c50">50</xref></sup>, which aids in the ‘weep and sweep’ pathogen elimination and may contribute to the maintenance of commensal communities in the gut<sup><xref ref-type="bibr" rid="c51">51</xref></sup>. This is consistent with our findings, which suggest that IL4 may be a central means by which frog mast cells confer protection against <italic>Bd,</italic> by counteracting <italic>Bd</italic>-elicited inflammation, including minimizing neutrophil infiltration, maintaining skin integrity, and promoting mucus production by skin mucus glands. The outcomes of cytokine signaling are critically dependent on timing, locations, and context<sup><xref ref-type="bibr" rid="c50">50</xref></sup>. This possibly explains why administering rIL4 prior to <italic>Bd</italic> challenge results in significant anti-<italic>Bd</italic> protection whereas treating already infected animals with this cytokine did not reduce fungal loads.</p>
<p>We anticipate that in addition to IL4 production, frog mast cells confer the observed antifungal protection through a myriad of additional mechanisms. Indeed, we observed elevated expression of antimicrobial peptide genes in the skins of mock-infected mast cell-enriched frogs 10 days after rSCF administration. The fact that we did not see the same expression patterns following <italic>Bd</italic> challenge could potentially reflect the highly immunomodulatory capacities of this pathogen<sup><xref ref-type="bibr" rid="c52">52</xref></sup>. Undoubtedly, frog skin-resident mast cells have evolved to contribute to and modulate skin antifungal antimicrobial peptide production just as <italic>Bd</italic> has undoubtedly coevolved to target this aspect of amphibian skin defenses.</p>
<p><italic>Bd</italic> infections caused major reductions in bacterial taxa richness, changes in composition and substantial increases in the relative abundance of <italic>Bd</italic>-inhibitory bacteria early in the infection. Similar changes to microbiome structure occur during experimental <italic>Bd</italic> infections, such as in red-backed salamanders and mountain yellow-legged frogs<sup><xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c53">53</xref></sup>. In turn, progressing <italic>Bd</italic> infections corresponded with a return to baseline levels of <italic>Bd</italic>-inhibitory bacteria abundance and rebounding microbial richness, albeit with dissimilar communities to those seen in control animals. These temporal changes indicate that amphibian microbiomes are dynamic, as are the effects of <italic>Bd</italic> infections on them. Indeed, <italic>Bd</italic> infections may have long-lasting impacts on amphibian microbiomes<sup><xref ref-type="bibr" rid="c8">8</xref></sup>, including the possible establishment of ‘ecological memory’, resulting in greater adaptation to subsequent pathogen exposures<sup><xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c54">54</xref></sup>. While <italic>Bd</italic> infections manifested in these considerable changes to frog skin microbiome structure, mast cell enrichment appeared to counteract the deleterious effects to their microbial composition. It will thus be interesting to learn from future studies how frog mast cells impact skin microbiome ecological memory. Presumably, the greater skin mucosal integrity and mucus production observed after mast cell enrichment served to stabilize the cutaneous environment during <italic>Bd</italic> infections, thereby ameliorating the <italic>Bd</italic>-mediated microbiome changes. While this work explored the changes in established antifungal flora, we anticipate the mast cell-mediated inhibition of <italic>Bd</italic> may be due to additional, yet unidentified bacterial, viral, or fungal taxa. Intriguingly, while mammalian skin mast cell functionality depends on microbiome elicited SCF production by keratinocytes<sup><xref ref-type="bibr" rid="c55">55</xref></sup>, our results indicate that frog skin mast cells in turn impact skin microbiome structure and likely their function. It will be interesting to further explore the interdependent nature of amphibian skin microbiomes and resident mast cells.</p>
<p>In contrast to the mast cell-mediated effects, enrichment of neutrophils seemed to result in greater <italic>Bd</italic> skin burdens. This suggests that neutrophils may result in a greater level of inflammation, which is not protective in the context of <italic>Bd</italic> infections. This is consistent with other studies that suggest that a strong immune response in the skin compartment of some species may be detrimental<sup><xref ref-type="bibr" rid="c56">56</xref>, <xref ref-type="bibr" rid="c57">57</xref></sup>.</p>
<p>Amphibian skin is much thinner and more permeable than that of mammals<sup><xref ref-type="bibr" rid="c7">7</xref></sup>, and as such, arguably represents a more penetrable barrier to pathogens. Because mammalian skin is relatively impermeable, mast cells are absent from healthy mammalian epidermises and are instead found exclusively in their dermal layers<sup><xref ref-type="bibr" rid="c58">58</xref></sup>. However, mammalian mast cells may infiltrate the skin epidermal layer during diseases such as dermatitis<sup><xref ref-type="bibr" rid="c59">59</xref></sup>. In contrast, we showed here and have observed across several classes of amphibians<sup><xref ref-type="bibr" rid="c16">16</xref></sup> that mast cells are found in both epidermal and dermal layers. This localization has presumably evolved to support the more intimate contact between amphibian skin and their environments. Considering the importance of amphibian cutaneous integrity to their physiology<sup><xref ref-type="bibr" rid="c60">60</xref></sup>, it is likely that skin-resident mast cells co-evolved to support skin immunity, physiology, and symbiotic microbiota. Ongoing research continues to reveal functional differences between mammalian connective tissue and mucosa-resident mast cells<sup><xref ref-type="bibr" rid="c61">61</xref></sup>, and we suspect that there is similarly much to learn about the distinct physiological and immune roles of amphibian epidermal and dermal mast cells.</p>
<p>Mammalian mast cells are thought to arise from two distinct lineages. Fetal-derived progenitors seed peripheral tissues during the neonatal life<sup><xref ref-type="bibr" rid="c62">62</xref></sup> and mature into long-lived connective tissue mast cells (CTMCs)<sup><xref ref-type="bibr" rid="c63">63</xref></sup>. Conversely, inducible mucosal mast cells (MMCs) arise from bone marrow–derived mast cell progenitors (MCps) and are recruited to mucosal tissues in response to inflammation<sup><xref ref-type="bibr" rid="c64">64</xref>, <xref ref-type="bibr" rid="c65">65</xref></sup>. The connective tissue mast cells are thought to possess significantly greater levels of heparin than bone marrow-derived mast cells<sup><xref ref-type="bibr" rid="c66">66</xref></sup>. Interestingly, the <italic>in vitro</italic> frog bone marrow-derived mast cells possessed substantially lower heparin content than what we observed in the skin-resident and <italic>Bd</italic>-recruited mast cells. Unlike the mammalian skin, frog skin is both a connective tissue and a mucosal barrier, begging the question of how the frog skin mast cells compare to the mammalian CTMCs and MMCs. It is interesting to consider that frog skin mast cells observed at steady state, following rSCF-enrichment, and recruited/expanded in response to <italic>Bd</italic>, all had substantial heparin levels. Possibly, the expansion of frog skin mast cell numbers in response to both rSCF and <italic>Bd</italic> is facilitated by skin-resident precursors, explaining the high heparin content observed in these populations. Of course, it is equally possible that amphibian mast cell ontogeny and heparin content are not the same as mammals. It will be invaluable to learn with future studies the origins, fates and immune consequences of distinct frog skin mast cell lineages and subsets.</p>
<p>It has become apparent that amphibian host-<italic>Bd</italic> interactions are highly complex and multifaceted while different amphibian species exhibit marked differences in their susceptibilities to this devastating pathogen<sup><xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c4">4</xref></sup>. The findings described here emphasize the importance of skin-resident mast cells for successful anti-<italic>Bd</italic> defenses and demonstrate that these immune sentinels are intimately linked to many aspects of frog skin physiology. Our results indicate that when mast cells are enriched, the ensuing changes in the skin allow for greater resistance to infection by developing zoospores. Presumably, distinct amphibian species have evolved disparate interconnections between their skin mast cells and their cutaneous defenses, as dictated by their respective physiological and environmental pressures. In turn, these species-specific differences likely dictate whether and to what extent the skin-resident mast cells of a given amphibian species recognize and appropriately respond to <italic>Bd</italic> infections. We postulate that such differences may contribute to the differences in susceptibilities of amphibian species to pathogens like chytrid fungi. Greater understanding of these relationships across disparate amphibian species holds promise of harnessing this knowledge towards possible development of preventative and therapeutic strategies against infectious diseases like chytridiomycosis.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Animals</title>
<p>Outbred 1 year-old (1.5-2”), mixed sex <italic>X. laevis</italic> were purchased from Xenopus 1 (Dexter, MI). All animals were housed and handled under strict laboratory regulations as per GWU IACUC (Approval number 15-024).</p>
</sec>
<sec id="s4b">
<title>Recombinant cytokines and bone marrow granulocyte cultures</title>
<p>The <italic>X. laevis</italic> rSCF, rCSF3 and rIL4 were generated as previously described for rCSF3<sup><xref ref-type="bibr" rid="c67">67</xref></sup> and as detailed in the supplemental materials.</p>
<p>Bone marrow isolation, culture conditions, and establishment of neutrophil cultures have been previously described<sup><xref ref-type="bibr" rid="c68">68</xref></sup>. Mast cell cultures were generated according to protocols adapted from Koubourli et al. (2018) and Meurer et al. (2016) <sup><xref ref-type="bibr" rid="c69">69</xref>, <xref ref-type="bibr" rid="c70">70</xref></sup>. Isolated bone marrow cells were treated with 250 ng/µl of rSCF on Day 0, Day 4, Day 7, and collected for further analysis on Day 9. Cell cultures were maintained at 27°C with 5% CO<sub>2</sub> in amphibian medium supplemented with 10% fetal bovine serum and 0.25% <italic>X. laevis</italic> serum. Neutrophil-like granulocytes were generated as above but with 250 ng/µl of rCSF3 on Day 0, Day 3, and collected for further analysis on Day 5. Cell cultures were maintained at 27°C with 5% CO<sub>2</sub> in amphibian serum-free medium supplemented with 10% fetal bovine serum, 0.25% <italic>X. laevis</italic> serum, 10 μg/mL gentamicin (Thermo Fisher Scientific, Waltham, Massachusetts, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco, Thermo Fisher Scientific).</p>
</sec>
<sec id="s4c">
<title>Enrichment of skin granulocyte subsets</title>
<p>Animals were subcutaneously injected between the skin and muscle layers with 5 µg/animal of rSCF, rCSF3, or r-ctrl in 5 µL of saline using finely pulled glass needles. Optimal time course and dose for <italic>in vivo</italic> mast cell and neutrophil enrichment were determined during preliminary experiments.</p>
</sec>
<sec id="s4d">
<title>Recombinant interleukin-4 treatment</title>
<p>The capacity of the recombinant interleukin-4 (rIL4) to induce expression of genes associated with mammalian IL4 responses were assessed by injecting frogs (<italic>N</italic>=6 per treatment group subcutaneously with rIL4 (5 µg/animal) or r-ctrl in 5 µl of saline. After 6hrs, animals were sacrificed, and skins were isolated for gene expression analyses.</p>
<p>To examine the effect of rIL4 on <italic>Bd</italic> loads, frogs were infected with <italic>Bd</italic> by water bath (10<sup>5</sup> zoospores/mL) as described below and 1 day later injected subcutaneously, dorsally with rIL4 (5 µg/animal) or r-ctrl in 5 µl of saline. After an additional 9 days of infection, animals were sacrificed and their dorsal skin <italic>Bd</italic> loads examined.</p>
</sec>
<sec id="s4e">
<title><italic>Bd</italic> stocks and fungal challenge</title>
<p><italic>Bd</italic> isolate JEL 197 was grown in 1% tryptone broth or on 1% tryptone agar plates (Difco Laboratories, Detroit, MI) supplemented with 100 U/mL penicillin and 100 μg/mL streptomycin (Gibco) at 19°C.</p>
<p><italic>In vitro Bd</italic> killing was evaluated by incubating live <italic>Bd</italic> (maturing zoosporangia) with mast cells or neutrophils at ratios of 5:1 or 1:1 <italic>Bd</italic> cells per granulocyte. Cells were incubated at 27°C for three days before fungal loads were analyzed by absolute qPCR. Experimental groups were compared to pathogen DNA amounts derived from equal quantities of live <italic>Bd</italic> plated alone in otherwise identical conditions.</p>
<p>For <italic>in vivo</italic> infection studies, zoospores were harvested by flooding confluent tryptone agar plates with 2 mL sterile A-PBS for 10 minutes. Twelve hours post rSCF, rCSF3, rIL4, or r-ctrl injection, animals were infected with 10<sup>7</sup> zoospores or mock-infected in 100 mL of water (10<sup>5</sup> zoospores/mL). After 3 hrs, 400 mL of water was added to each tank. Skins were collected for histology and gene expression analyses on 1, 10, and 21 dpi with 10 and 21 dpi representing intermediate and later timepoints of infection, respectively.</p>
</sec>
<sec id="s4f">
<title>Histology</title>
<p>Leukocyte cytology and cutaneous SE staining has been described<sup><xref ref-type="bibr" rid="c67">67</xref></sup> and is detailed in the supplemental materials. An Alcian Blue/PAS staining kit (Newcomer Supply, Middleton, WI) was used to quantify mucin content. Histology is detailed in the supplemental materials.</p>
</sec>
<sec id="s4g">
<title>Electron Microscopy</title>
<p>Processing and imaging of cells for transmission and scanning electron microscopy (TEM and SEM) was conducted at the GWU Nanofabrication and Imaging Center (GWNIC). For transmission electron microscopy, cells were fixed as monolayers on six-well plates with 2.5% glutaraldehyde and 1% paraformaldehyde in 0.1 M sodium cacodylate buffer for one hour. Cells were treated with 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for 1 hr. Following washes, cells were <italic>en bloc</italic> stained with 1% uranyl acetate in water overnight at 4°C. Samples were dehydrated through an ethanol series and embedded in epoxy resin using LX112. Inverted Beem capsules were placed into each tissue culture well to create <italic>on face</italic> blockfaces for sectioning. Resin was cured for 48 hrs at 60°C. The 95 nm sections were post-stained with 1% aqueous uranyl acetate and Reynold’s lead citrate. All imaging was performed at 80 KV in a Talos 200X transmission electron microscope (Thermo Fisher Scientific, Hillsboro, OR).</p>
<p>For SEM, cells were fixed with 2.5% glutaraldehyde / 1% paraformaldehyde in Sodium cacodylate buffer, followed by 1% OsO<sub>4</sub>, then dehydrated through an ethyl alcohol series. Coverslips were critical point dried and coated with 2 nm iridium. Cells were imaged using a Teneo Scanning Electron Microscope (Thermo Fisher Scientific).</p>
</sec>
<sec id="s4h">
<title>Analyses of immune gene expression and <italic>Bd</italic> skin loads</title>
<p>These analyses have been described<sup><xref ref-type="bibr" rid="c67">67</xref></sup> and are detailed in supplemental materials.</p>
</sec>
<sec id="s4i">
<title>RNA sequencing</title>
<p>For transcriptomic profiling, bone marrow-derived neutrophil and mast cell cultures were generated as described above and FACS-sorted according to preestablished size and internal complexity parameters to isolate the respective subsets for further analyses. Sorted cells were immediately processed to extract and purify RNA. Flash frozen samples were sent to Azenta Life Sciences for all library preparation, RNA sequencing, and analyses. In short, polyadenylated RNA was isolated using Oligo dT beads. Enriched mRNAs were then fragmented for first and second strand cDNA synthesis. cDNA fragments were end repaired, 5’ phosphorylated, and dA-tailed. Fragments were then ligated to universal adaptors and PCR-amplified. 150-bp paired-end sequencing was performed on an Illumina HiSeq platform.</p>
<p>FastQC was used to evaluate raw data quality. Adaptors sequences and poor-quality nucleotides were removed from reads using Trimmomatic v.0.36. The STAR aligner v.2.55.2b was used to map these reads to the Xenopus_laevis_9_2 reference genome from ENSEMBL. To determine differential gene expression, featureCount (Subread package v.1.5.2) was first used to count unique gene hits, which were then used with DESeq2 to calculate absolute log<sub>2-</sub>fold change.</p>
</sec>
<sec id="s4j">
<title>Skin microbiome analyses</title>
<p>Towards microbiome studies, frogs were housed individually (N=6/treatment group). At indicated times, frogs were gently rinsed with sterile deionized water to remove transient microbes and gently swabbed 20 times, dorsally. Genomic DNA was extracted from swabs using a PowerSoil Pro kit on a Qiacube HT (QIAGEN, MD). One-step PCR library prep and dual-index paired-end Illumina sequencing was used to sequence the skin microbiome of individual frogs. A ∼380 base pair region in the V3-V5 region of the 16S rRNA gene using the universal primers 515F-Y (GTGYCAGCMGCCGCGGTAA) and 939R (CTTGTGCGGGCCCCCGTCAATTC) was used for amplification. Negative and positive controls (ZymoBIOMICS D6300 &amp; D6305, Zymo, CA) were included in each round of extraction and PCR. Reactions were done in duplicate for each sample, pooled, cleaned with in-house Speed-beads (in a PEG/NaCl buffer), quantified with a Qubit4 (Invitrogen, MA) and pooled into a final library in equimolar proportion. The pooled library was sequenced on two Illumina MiSeq runs (v3 chemistry: 2×300 bp kit) at the Center for Conservation Genomics, Smithsonian National Zoo &amp; Conservation Biology Institute.</p>
<p>Analyses were performed in the R environment version 4.0.3 (R Core Team, 2020) using methods detailed in the supplemental materials.</p>
</sec>
<sec id="s4k">
<title>Statistical analyses</title>
<p>Differences in transcript expression were calculated with one-way or multi-way ANOVAs followed by Tukey post-hoc tests. Student’s t-tests were used to determine differences in <italic>Bd</italic> loads between treatments only. Statistical differences in mucin content and mucosome <italic>Bd</italic>-killing were assessed with the two-way ANOVA calculator available online through Statistics Kingdom. For RNA sequencing, <italic>p</italic>-values were calculated with the Wald test and were adjusted using the Benjamini-Hochberge procedure.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Dr. Cynthia S. Dowd and Ben England (Chemistry Department, GWU) for their help with <italic>X. laevis</italic> mucus lyophilization. We thank Dr. Christine Brantner (GWU Nanofabrication and imaging center) for assistance with TEM and SEM imaging. KAH, MRHH, and AY were supported by Wilbur V. Harlan summer graduate research fellowships. We thank Dr. Alexander Jeremic (GWU) for access to and use of his confocal microscope. We thank Dr. Gregory Cresswell (GWU) for his help with flow cytometry and cell sorting. KAH, MRHH, NR, NK, AY, MZ, and LG thank the GWU Biology Department. We thank the three anonymous reviewers whose insightful comments and suggestions helped to improve the scope and breadth of this manuscript.</p>
</ack>
<sec id="s5">
<title>Funding</title>
<p>National Science Foundation grant 2131061 (LG, CRMW)</p>
<p>National Science Foundation grant 2147466 (LG)</p>
<p>National Science Foundation grant 2147467 (LAR-S)</p>
<sec id="s5a">
<title>Author contributions</title>
<p>Conceptualization: KAH, LG</p>
<p>Methodology: KAH, CNG, RSC, MRHH, DTH, NR, LKG, AY, NK, MZ, EJJ, AND, LAR-S, CRMW, LG</p>
<p>Investigation: KAH, CNG, RSC, MRHH, DTH, NR, LKG, AY, NK, MZ, EJJ, AND, LAR-S, CRMW, LG</p>
<p>Visualization: KAH, CNG, RSC, EJJ, AND, LG</p>
<p>Funding acquisition: LG, CRMW, LAR-S</p>
<p>Project administration: LG</p>
<p>Supervision: LG, CRMW, LAR-S</p>
<p>Writing – original draft: KAH, LAR-S, CRMW, LG</p>
<p>Writing – review &amp; editing: KAH, LAR-S, CRMW, LG</p>
</sec>
</sec>
<sec id="s6">
<title>Competing interests</title>
<p>The authors declare no competing interests.</p>
</sec>
<sec id="s7">
<title>Data and materials availability</title>
<p>All data are available in the main text or the supplementary materials.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Martel</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>Wildlife disease. Recent introduction of a chytrid fungus endangers Western Palearctic salamanders</article-title>. <source>Science</source> <volume>346</volume>, <fpage>630</fpage>–<lpage>631</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Scheele</surname>, <given-names>B.C.</given-names></string-name> <etal>et al.</etal> <article-title>Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity</article-title>. <source>Science</source> <volume>363</volume>, <fpage>1459</fpage>–<lpage>1463</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Van Rooij</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Martel</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Haesebrouck</surname>, <given-names>F.</given-names></string-name> &amp; <string-name><surname>Pasmans</surname>, <given-names>F</given-names></string-name>. <article-title>Amphibian chytridiomycosis: a review with focus on fungus-host interactions</article-title>. <source>Veterinary research</source> <volume>46</volume>, <fpage>1</fpage>–<lpage>22</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Van Rooij</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title>Development of in vitro models for a better understanding of the early pathogenesis of Batrachochytrium dendrobatidis infections in amphibians</article-title>. <source>Altern Lab Anim</source> <volume>38</volume>, <fpage>519</fpage>–<lpage>528</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Voyles</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Pathogenesis of chytridiomycosis, a cause of catastrophic amphibian declines</article-title>. <source>Science</source> <volume>326</volume>, <fpage>582</fpage>–<lpage>585</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Rollins-Smith</surname>, <given-names>L.A</given-names></string-name>. <article-title>The importance of antimicrobial peptides (AMPs) in amphibian skin defense</article-title>. <source>Dev Comp Immunol</source> <volume>142</volume>, <fpage>104657</fpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Varga</surname>, <given-names>J.F.A.</given-names></string-name>, <string-name><surname>Bui-Marinos</surname>, <given-names>M.P.</given-names></string-name> &amp; <string-name><surname>Katzenback</surname>, <given-names>B.A</given-names></string-name>. <article-title>Frog Skin Innate Immune Defences: Sensing and Surviving Pathogens</article-title>. <source>Front Immunol</source> <volume>9</volume>, <fpage>3128</fpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Jani</surname>, <given-names>A.J.</given-names></string-name> <etal>et al.</etal> <article-title>The amphibian microbiome exhibits poor resilience following pathogen-induced disturbance</article-title>. <source>ISME J</source> <volume>15</volume>, <fpage>1628</fpage>–<lpage>1640</lpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Woodhams</surname>, <given-names>D.C.</given-names></string-name>, <string-name><surname>McCartney</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Walke</surname>, <given-names>J.B.</given-names></string-name> &amp; <string-name><surname>Whetstone</surname>, <given-names>R</given-names></string-name>. <article-title>The adaptive microbiome hypothesis and immune interactions in amphibian mucus</article-title>. <source>Dev Comp Immunol</source>, <volume>104690</volume> (<year>2023</year>).</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Rodriguez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Rollins-Smith</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ibanez</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Durant-Archibold</surname>, <given-names>A.A.</given-names></string-name> &amp; <string-name><surname>Gutierrez</surname>, <given-names>M</given-names></string-name>. <article-title>Toxins and pharmacologically active compounds from species of the family Bufonidae (Amphibia, Anura)</article-title>. <source>J Ethnopharmacol</source> <volume>198</volume>, <fpage>235</fpage>–<lpage>254</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Grogan</surname>, <given-names>L.F.</given-names></string-name> <etal>et al.</etal> <article-title>Review of the Amphibian Immune Response to Chytridiomycosis, and Future Directions</article-title>. <source>Front Immunol</source> <volume>9</volume>, <fpage>2536</fpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Rollins-Smith</surname>, <given-names>L.A.</given-names></string-name> <etal>et al.</etal> <article-title>Immune defenses of Xenopus laevis against Batrachochytrium dendrobatidis</article-title>. <source>Front Biosci (Schol Ed)</source> <volume>1</volume>, <fpage>68</fpage>–<lpage>91</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Ramsey</surname>, <given-names>J.P.</given-names></string-name>, <string-name><surname>Reinert</surname>, <given-names>L.K.</given-names></string-name>, <string-name><surname>Harper</surname>, <given-names>L.K.</given-names></string-name>, <string-name><surname>Woodhams</surname>, <given-names>D.C.</given-names></string-name> &amp; <string-name><surname>Rollins-Smith</surname>, <given-names>L.A</given-names></string-name>. <article-title>Immune defenses against Batrachochytrium dendrobatidis, a fungus linked to global amphibian declines, in the South African clawed frog, Xenopus laevis</article-title>. <source>Infect Immun</source> <volume>78</volume>, <fpage>3981</fpage>–<lpage>3992</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>McMahon</surname>, <given-names>T.A.</given-names></string-name> <etal>et al.</etal> <article-title>Amphibians acquire resistance to live and dead fungus overcoming fungal immunosuppression</article-title>. <source>Nature</source> <volume>511</volume>, <fpage>224</fpage>–<lpage>227</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Sobiepanek</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>The multifaceted roles of mast cells in immune homeostasis, infections and cancers</article-title>. <source>International Journal of Molecular Sciences</source> <volume>23</volume>, <fpage>2249</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Hauser</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Garvey</surname>, <given-names>C.N.</given-names></string-name>, <string-name><surname>Popovic</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Grayfer</surname>, <given-names>L</given-names></string-name>. <article-title>Biology of amphibian granulocytes - From evolutionary pressures to functional consequences</article-title>. <source>Dev Comp Immunol</source> <volume>140</volume>, <fpage>104623</fpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Allen</surname>, <given-names>J.E</given-names></string-name>. <article-title>IL-4 and IL-13: Regulators and Effectors of Wound Repair</article-title>. <source>Annu Rev Immunol</source> <volume>41</volume>, <fpage>229</fpage>–<lpage>254</lpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>McNeil</surname>, <given-names>H.P.</given-names></string-name>, <string-name><surname>Adachi</surname>, <given-names>R.</given-names></string-name> &amp; <string-name><surname>Stevens</surname>, <given-names>R.L</given-names></string-name>. <article-title>Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense</article-title>. <source>Journal of Biological Chemistry</source> <volume>282</volume>, <fpage>20785</fpage>–<lpage>20789</lpage> (<year>2007</year>).</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Abraham</surname>, <given-names>S.N.</given-names></string-name> &amp; <string-name><surname>St John</surname>, <given-names>A.L</given-names></string-name>. <article-title>Mast cell-orchestrated immunity to pathogens</article-title>. <source>Nature reviews.Immunology</source> <volume>10</volume>, <fpage>440</fpage>–<lpage>452</lpage> (<year>2010</year>).</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Baccari</surname>, <given-names>G.C.</given-names></string-name>, <string-name><surname>Pinelli</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Santillo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Minucci</surname>, <given-names>S.</given-names></string-name> &amp; <string-name><surname>Rastogi</surname>, <given-names>R.K</given-names></string-name>. <article-title>Mast cells in nonmammalian vertebrates: an overview</article-title>. <source>International review of cell and molecular biology</source> <volume>290</volume>, <fpage>1</fpage>–<lpage>53</lpage> (<year>2011</year>).</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Ito</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title>Stem cell factor programs the mast cell activation phenotype</article-title>. <source>J Immunol</source> <volume>188</volume>, <fpage>5428</fpage>–<lpage>5437</lpage> (<year>2012</year>).</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Yaparla</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wendel</surname>, <given-names>E.S.</given-names></string-name> &amp; <string-name><surname>Grayfer</surname>, <given-names>L</given-names></string-name>. <article-title>The unique myelopoiesis strategy of the amphibian Xenopus laevis</article-title>. <source>Developmental &amp; Comparative Immunology</source> <volume>63</volume>, <fpage>136</fpage>–<lpage>143</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Espinosa-Riquer</surname>, <given-names>Z.P.</given-names></string-name> <etal>et al.</etal> <article-title>Signal transduction pathways activated by innate immunity in mast cells: translating sensing of changes into specific responses</article-title>. <source>Cells</source> <volume>9</volume>, <fpage>2411</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Cildir</surname>, <given-names>G.</given-names></string-name> <etal>et al.</etal> <article-title>Understanding mast cell heterogeneity at single cell resolution</article-title>. <source>Trends in Immunology</source> <volume>42</volume>, <fpage>523</fpage>–<lpage>535</lpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Paudel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ghimire</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Jin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Jeansonne</surname>, <given-names>D.</given-names></string-name> &amp; <string-name><surname>Jeyaseelan</surname>, <given-names>S</given-names></string-name>. <article-title>Regulation of emergency granulopoiesis during infection</article-title>. <source>Front Immunol</source> <volume>13</volume>, <fpage>961601</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Atiakshin</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal> <article-title>Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells</article-title>. <source>Cells</source> <volume>11</volume> (<year>2022</year>).</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Baban</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title>IDO activates regulatory T cells and blocks their conversion into Th17-like T cells</article-title>. <source>J Immunol</source> <volume>183</volume>, <fpage>2475</fpage>–<lpage>2483</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Banner</surname>, <given-names>L.R.</given-names></string-name>, <string-name><surname>Patterson</surname>, <given-names>P.H.</given-names></string-name>, <string-name><surname>Allchorne</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Poole</surname>, <given-names>S.</given-names></string-name> &amp; <string-name><surname>Woolf</surname>, <given-names>C.J</given-names></string-name>. <article-title>Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine</article-title>. <source>J Neurosci</source> <volume>18</volume>, <fpage>5456</fpage>–<lpage>5462</lpage> (<year>1998</year>).</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Agis</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title>Mast Cell-Lineage Versus Basophil Lineage Involvement in Myeloproliferative and Myelodysplastic Syndromes: Diagnostic Role of Cell-Immunopheno typing</article-title>. <source>Leukemia &amp; lymphoma</source> <volume>22</volume>, <fpage>187</fpage>–<lpage>204</lpage> (<year>1996</year>).</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Tharp</surname>, <given-names>M.D.</given-names></string-name>, <string-name><surname>Seelig</surname>, <given-names>L.L.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Tigelaar</surname>, <given-names>R.E.</given-names></string-name> &amp; <string-name><surname>Bergstresser</surname>, <given-names>P.R</given-names></string-name>. <article-title>Conjugated avidin binds to mast cell granules</article-title>. <source>J Histochem Cytochem</source> <volume>33</volume>, <fpage>27</fpage>–<lpage>32</lpage> (<year>1985</year>).</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Kiritsi</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Has</surname>, <given-names>C.</given-names></string-name> &amp; <string-name><surname>Bruckner-Tuderman</surname>, <given-names>L</given-names></string-name>. <article-title>Laminin 332 in junctional epidermolysis bullosa</article-title>. <source>Cell Adh Migr</source> <volume>7</volume>, <fpage>135</fpage>–<lpage>141</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Ho</surname>, <given-names>W.L.</given-names></string-name> <etal>et al.</etal> <article-title>B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma</article-title>. <source>Cancer Sci</source> <volume>104</volume>, <fpage>1600</fpage>–<lpage>1608</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>, <given-names>E.H.</given-names></string-name>, <string-name><surname>Van Camp</surname>, <given-names>G.</given-names></string-name> &amp; <string-name><surname>Smith</surname>, <given-names>R.J</given-names></string-name>. <article-title>The role of connexins in human disease</article-title>. <source>Ear Hear</source> <volume>24</volume>, <fpage>314</fpage>–<lpage>323</lpage> (<year>2003</year>).</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Taupin</surname>, <given-names>D.</given-names></string-name> &amp; <string-name><surname>Podolsky</surname>, <given-names>D.K</given-names></string-name>. <article-title>Trefoil factors: initiators of mucosal healing</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>4</volume>, <fpage>721</fpage>–<lpage>732</lpage> (<year>2003</year>).</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Fischer</surname>, <given-names>H</given-names></string-name>. <article-title>Mechanisms and function of DUOX in epithelia of the lung</article-title>. <source>Antioxid Redox Signal</source> <volume>11</volume>, <fpage>2453</fpage>–<lpage>2465</lpage> (<year>2009</year>).</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>Inhibition of Gabrp reduces the differentiation of airway epithelial progenitor cells into goblet cells</article-title>. <source>Exp Ther Med</source> <volume>22</volume>, <fpage>720</fpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>J</given-names></string-name>. <article-title>Neutrophils in tissue injury and repair</article-title>. <source>Cell Tissue Res</source> <volume>371</volume>, <fpage>531</fpage>–<lpage>539</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Roberts</surname>, <given-names>A.W</given-names></string-name>. <article-title>G-CSF: a key regulator of neutrophil production, but that’s not all!</article-title> <source>Growth Factors</source> <volume>23</volume>, <fpage>33</fpage>–<lpage>41</lpage> (<year>2005</year>).</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Koubourli</surname>, <given-names>V.D.</given-names></string-name>, <string-name><surname>Wendel</surname>, <given-names>E.S.</given-names></string-name>, <string-name><surname>Yaparla</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ghaul</surname>, <given-names>J.R.</given-names></string-name> &amp; <string-name><surname>Grayfer</surname>, <given-names>L</given-names></string-name>. <article-title>Immune roles of amphibian (Xenopus laevis) tadpole granulocytes during Frog Virus 3 ranavirus infections</article-title>. <source>Dev Comp Immunol</source> <volume>72</volume>, <fpage>112</fpage>–<lpage>118</lpage> (<year>2017</year>).</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Yaparla</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wendel</surname>, <given-names>E.S.</given-names></string-name> &amp; <string-name><surname>Grayfer</surname>, <given-names>L</given-names></string-name>. <article-title>The unique myelopoiesis strategy of the amphibian Xenopus laevis</article-title>. <source>Dev Comp Immunol</source> <volume>63</volume>, <fpage>136</fpage>–<lpage>143</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Buchan</surname>, <given-names>K.D.</given-names></string-name> <etal>et al.</etal> <article-title>A transgenic zebrafish line for in vivo visualisation of neutrophil myeloperoxidase</article-title>. <source>PLoS One</source> <volume>14</volume>, <fpage>e0215592</fpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Woodhams</surname>, <given-names>D.C.</given-names></string-name> <etal>et al.</etal> <article-title>Antifungal isolates database to centralize data on amphibian ski associated bacteria and their function against emerging fungal pathogens including Batrachochytrium dendrobatidis</article-title>. <source>Ecology</source> <volume>96</volume>, <fpage>595</fpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Patocka</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Nepovimova</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Klimova</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Q.</given-names></string-name> &amp; <string-name><surname>Kuca</surname>, <given-names>K</given-names></string-name>. <article-title>Antimicrobial peptides: amphibian host defense peptides</article-title>. <source>Current medicinal chemistry</source> <volume>26</volume>, <fpage>5924</fpage>–<lpage>5946</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Di Nardo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yamasaki</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Dorschner</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Lai</surname>, <given-names>Y.</given-names></string-name> &amp; <string-name><surname>Gallo</surname>, <given-names>R.L</given-names></string-name>. <article-title>Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin</article-title>. <source>J Immunol</source> <volume>180</volume>, <fpage>7565</fpage>–<lpage>7573</lpage> (<year>2008</year>).</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Babina</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Guhl</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Artuc</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Zuberbier</surname>, <given-names>T</given-names></string-name>. <article-title>IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure</article-title>. <source>Archives of dermatological research</source> <volume>308</volume>, <fpage>665</fpage>–<lpage>670</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Bhattacharjee</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title>IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages</article-title>. <source>Free Radic Biol Med</source> <volume>54</volume>, <fpage>1</fpage>–<lpage>16</lpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="web"><ext-link ext-link-type="uri" xlink:href="https://www.iucnredlist.org/resources/summary-statistics">https://www.iucnredlist.org/resources/summary-statistics</ext-link>, I.R.L.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Fisher</surname>, <given-names>M.C.</given-names></string-name> &amp; <string-name><surname>Garner</surname>, <given-names>T.W</given-names></string-name>. <article-title>Chytrid fungi and global amphibian declines</article-title>. <source>Nature Reviews Microbiology</source> <volume>18</volume>, <fpage>332</fpage>–<lpage>343</lpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>St. John</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Rathore</surname>, <given-names>A.P.</given-names></string-name> &amp; <string-name><surname>Ginhoux</surname>, <given-names>F</given-names></string-name>. <article-title>New perspectives on the origins and heterogeneity of mast cells</article-title>. <source>Nature Reviews Immunology</source> <volume>23</volume>, <fpage>55</fpage>–<lpage>68</lpage> (<year>2023</year>).</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Redpath</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Heieis</surname>, <given-names>G.</given-names></string-name> &amp; <string-name><surname>Perona-Wright</surname>, <given-names>G</given-names></string-name>. <article-title>Spatial regulation of IL-4 signalling in vivo</article-title>. <source>Cytokine</source> <volume>75</volume>, <fpage>51</fpage>–<lpage>56</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Drago</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title>Bacteria Living in Biofilms in Fluids: Could Chemical Antibiofilm Pretreatment of Culture Represent a Paradigm Shift in Diagnostics?</article-title> <source>Microorganisms</source> <volume>12</volume> (<year>2024</year>).</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Rollins-Smith</surname>, <given-names>L.A.</given-names></string-name> &amp; <string-name><surname>Le Sage</surname>, <given-names>E.H</given-names></string-name>. <article-title>Batrachochytrium fungi: stealth invaders in amphibian skin</article-title>. <source>Curr Opin Microbiol</source> <volume>61</volume>, <fpage>124</fpage>–<lpage>132</lpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Muletz-Wolz</surname>, <given-names>C.R.</given-names></string-name>, <string-name><surname>Fleischer</surname>, <given-names>R.C.</given-names></string-name> &amp; <string-name><surname>Lips</surname>, <given-names>K.R</given-names></string-name>. <article-title>Fungal disease and temperature alter skin microbiome structure in an experimental salamander system</article-title>. <source>Mol Ecol</source> <volume>28</volume>, <fpage>2917</fpage>–<lpage>2931</lpage> (<year>2019</year>).</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Letourneau</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title>Ecological memory of prior nutrient exposure in the human gut microbiome</article-title>. <source>ISME J</source> <volume>16</volume>, <fpage>2479</fpage>–<lpage>2490</lpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>Z.</given-names></string-name> <etal>et al.</etal> <article-title>Skin microbiome promotes mast cell maturation by triggering stem cell factor production in keratinocytes</article-title>. <source>J Allergy Clin Immunol</source> <volume>139</volume>, <fpage>1205</fpage>–<lpage>1216</lpage> e1206 (<year>2017</year>).</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Ellison</surname>, <given-names>A.R.</given-names></string-name> <etal>et al.</etal> <article-title>More than skin deep: functional genomic basis for resistance to amphibian chytridiomycosis</article-title>. <source>Genome Biol Evol</source> <volume>7</volume>, <fpage>286</fpage>–<lpage>298</lpage> (<year>2014</year>).</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Savage</surname>, <given-names>A.E.</given-names></string-name>, <string-name><surname>Gratwicke</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Hope</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bronikowski</surname>, <given-names>E.</given-names></string-name> &amp; <string-name><surname>Fleischer</surname>, <given-names>R.C</given-names></string-name>. <article-title>Sustained immune activation is associated with susceptibility to the amphibian chytrid fungus</article-title>. <source>Mol Ecol</source> <volume>29</volume>, <fpage>2889</fpage>–<lpage>2903</lpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Cowen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Trigg</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Eady</surname>, <given-names>R.A</given-names></string-name>. <article-title>Distribution of mast cells in human dermis: development of a mapping technique</article-title>. <source>Br J Dermatol</source> <volume>100</volume>, <fpage>635</fpage>–<lpage>640</lpage> (<year>1979</year>).</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Imayama</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shibata</surname>, <given-names>Y.</given-names></string-name> &amp; <string-name><surname>Hori</surname>, <given-names>Y</given-names></string-name>. <article-title>Epidermal mast cells in atopic dermatitis</article-title>. <source>Lancet</source> <volume>346</volume>, <fpage>1559</fpage> (<year>1995</year>).</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Larsen</surname>, <given-names>E.H</given-names></string-name>. <article-title>Dual skin functions in amphibian osmoregulation</article-title>. <source>Comparative Biochemistry and Physiology Part A: Molecular &amp; Integrative Physiology</source> <volume>253</volume>, <fpage>110869</fpage> (<year>2021</year>).</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>West</surname>, <given-names>P.W.</given-names></string-name> &amp; <string-name><surname>Bulfone-Paus</surname>, <given-names>S</given-names></string-name>. <article-title>Mast cell tissue heterogeneity and specificity of immune cell recruitment</article-title>. <source>Front Immunol</source> <volume>13</volume>, <fpage>932090</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Gentek</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title>Hemogenic Endothelial Fate Mapping Reveals Dual Developmental Origin of Mast Cells</article-title>. <source>Immunity</source> <volume>48</volume>, <fpage>1160</fpage>–<lpage>1171</lpage> e1165 (<year>2018</year>).</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Dwyer</surname>, <given-names>D.F.</given-names></string-name>, <string-name><surname>Barrett</surname>, <given-names>N.A.</given-names></string-name>, <string-name><surname>Austen</surname>, <given-names>K.F.</given-names></string-name> &amp; <collab>Immunological Genome Project, C</collab>. <article-title>Expression profiling of constitutive mast cells reveals a unique identity within the immune system</article-title>. <source>Nat Immunol</source> <volume>17</volume>, <fpage>878</fpage>–<lpage>887</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Bankova</surname>, <given-names>L.G.</given-names></string-name>, <string-name><surname>Dwyer</surname>, <given-names>D.F.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>A.Y.</given-names></string-name>, <string-name><surname>Austen</surname>, <given-names>K.F.</given-names></string-name> &amp; <string-name><surname>Gurish</surname>, <given-names>M.F</given-names></string-name>. <article-title>Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice</article-title>. <source>Mucosal Immunol</source> <volume>8</volume>, <fpage>596</fpage>–<lpage>606</lpage> (<year>2015</year>).</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name> <etal>et al.</etal> <article-title>Adult Connective Tissue-Resident Mast Cells Originate from Late Erythro-Myeloid Progenitors</article-title>. <source>Immunity</source> <volume>49</volume>, <fpage>640</fpage>–<lpage>653</lpage> e645 (<year>2018</year>).</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Herrera-Heredia</surname>, <given-names>S.A.</given-names></string-name> <etal>et al.</etal> <article-title>Heparin is required for the formation of granules in connective tissue mast cells</article-title>. <source>Front Immunol</source> <volume>13</volume>, <fpage>1000405</fpage> (<year>2022</year>).</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Hauser</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title>Discovery of granulocyte-lineage cells in the skin of the amphibian Xenopus laevis</article-title>. <source>FACETS</source> <volume>5</volume>, <fpage>571</fpage> (<year>2020</year>).</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Yaparla</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Grayfer</surname>, <given-names>L</given-names></string-name>. <article-title>Isolation and culture of amphibian (Xenopus laevis) sub-capsular liver and bone marrow cells</article-title>. <source>Xenopus: Methods and Protocols</source>, <fpage>275</fpage>–<lpage>281</lpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Koubourli</surname>, <given-names>D.V.</given-names></string-name>, <string-name><surname>Yaparla</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Popovic</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Grayfer</surname>, <given-names>L</given-names></string-name>. <article-title>Amphibian (Xenopus laevis) interleukin-8 (CXCL8): a perspective on the evolutionary divergence of granulocyte chemotaxis</article-title>. <source>Frontiers in immunology</source>, <fpage>2058</fpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Meurer</surname>, <given-names>S.K.</given-names></string-name> <etal>et al.</etal> <article-title>Isolation of mature (peritoneum-derived) mast cells and immature (bone marrow-derived) mast cell precursors from mice</article-title>. <source>PLoS One</source> <volume>11</volume>, <fpage>e0158104</fpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Callahan</surname>, <given-names>B.J.</given-names></string-name> <etal>et al.</etal> <article-title>DADA2: High-resolution sample inference from Illumina amplicon data</article-title>. <source>Nat Methods</source> <volume>13</volume>, <fpage>581</fpage>–<lpage>583</lpage> (<year>2016</year>).</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>McMurdie</surname>, <given-names>P.J.</given-names></string-name> &amp; <string-name><surname>Holmes</surname>, <given-names>S.</given-names></string-name> <article-title>phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e61217</fpage> (<year>2013</year>).</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Davis</surname>, <given-names>N.M.</given-names></string-name>, <string-name><surname>Proctor</surname>, <given-names>D.M.</given-names></string-name>, <string-name><surname>Holmes</surname>, <given-names>S.P.</given-names></string-name>, <string-name><surname>Relman</surname>, <given-names>D.A.</given-names></string-name> &amp; <string-name><surname>Callahan</surname>, <given-names>B.J</given-names></string-name>. <article-title>Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data</article-title>. <source>Microbiome</source> <volume>6</volume>, <fpage>226</fpage> (<year>2018</year>).</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Jimenez</surname>, <given-names>R.R.</given-names></string-name> <etal>et al.</etal> <article-title>Inhibitory Bacterial Diversity and Mucosome Function Differentiate Susceptibility of Appalachian Salamanders to Chytrid Fungal Infection</article-title>. <source>Appl Environ Microbiol</source> <volume>88</volume>, <fpage>e0181821</fpage> (<year>2022</year>).</mixed-citation></ref>
</ref-list>
<sec id="s8">
<title>Supplementary materials</title>
<sec id="s8a">
<title>Production of recombinant cytokines</title>
<p>The <italic>X. laevis</italic> SCF and CSF3 sequences representing the signal peptide-cleaved transcripts were ligated into the pMIB/V5 His A insect expression vectors (Invitrogen). SCF-ligated, CSF3-ligated, or empty vectors were transfected into Sf9 insect cells (cellfectin II, Invitrogen). Recombinant proteins contain a V5 epitope, and western blot with an anti-V5-HRP antibody (Sigma) confirmed their presence. Positive transfectants were selected using 10 μg/mL blasticidin (Gibco). Expression cultures were scaled up to 500 mL liquid cultures, grown for 5 days, pelleted by centrifugation, and the supernatants collected. Supernatants were dialyzed overnight at 4°C against 150 mM sodium phosphate, concentrated against polyethylene glycol flakes (8 kDa) at 4°C, dialyzed overnight at 4°C against 150 mM sodium phosphate, and passed through Ni-NTA agarose columns (Qiagen). Columns were washed with 2 × 10 volumes of high stringency wash buffer (0.5% Tween 20, 50 mM Sodium Phosphate, 500 mM Sodium Chloride, 100 mM Imidazole) and 5 × 10 volumes of low stringency wash buffer (as above but with 40 mM Imidazole). Recombinant proteins were eluted with 250 mM imidazole. After recombinant protein purification, a halt protease inhibitor cocktail (containing AEBSF, aprotinin, bestatin, E-64, leupeptin and pepstatin A; Thermo Scientific) was added. Intact recombinant protein presence was confirmed again by western blot and the protein concentrations quantified by Bradford protein assays (BioRad). Protein aliquots were stored at −20°C until use.</p>
</sec>
<sec id="s8b">
<title>Bone marrow granulocyte cultures</title>
<p>Bone marrow cells were isolated as previously described <sup><xref ref-type="bibr" rid="c68">68</xref></sup>. Briefly, adult <italic>X. laevis</italic> (approximately one year old) were euthanized in 5% tricaine mesylate followed by cervical dislocation. Femurs were removed and washed in ice-cold Amphibian-PBS (A-PBS) in sterile conditions. Each femur was flushed with 5 mL of A-PBS. Red blood cells were removed from culture via a differential gradient generated with 51% Percoll. Bone marrow cell counts were generated using trypan blue exclusion and cells were seeded at a density of 10<sup>4</sup> cells/well for gene expression experiments, 5×10<sup>4</sup> cells/well for histology analyses, and 10<sup>5</sup> cells/well for electron microscopy analyses.</p>
</sec>
<sec id="s8c">
<title>Histology</title>
<p>Paraffin-embedded tissue sections (5 μm) were deparaffinized, rehydrated through A-PBS, and stained with Naphthol AS-D Chloroacetate (specific esterase; Sigma) or Alcian Blue/PAS (Newcomer, Middleton, WI) according to the manufacturers’ instructions and optimized for <italic>Xenopus</italic> skin tissues. Cells collected from <italic>in vitro</italic> cultures were cytocentrifuged onto glass microscope slides (VWR). Cells were stained immediately with Giemsa (Sigma) for 7 minutes or fixed with 10% neutral buffered formalin for 30 minutes and stained with specific esterase according to the manufacturers’ instructions. Slides stained with Alcian Blue/PAS (Newcomer) were used to quantify mucin content from <italic>in vivo</italic> experiments. Images were taken using identical microscope settings under 20x magnification. Images were converted to 8-bit in Fiji by ImageJ and threshold adjusted such that positive staining for mucus was captured within the mucus glands (threshold held constant across images). The percentage of each mucus gland positively stained and the average percent-positive per field of view were subsequently calculated. Positive staining of both acidic and neutral mucins was included in analyses. ImageJ was also used for epidermal thickness analyses, using scale bars in the images to calibrate and measure epidermal thickness. All slides were imaged with a Leica DMi8 Inverted Fluorescent Microscope with all mucus glands assessed for each respective frog skin section (Leica Microsystems, Davie, FL).</p>
<p>An RNAScope ISH Kit (ACD Bio) and a <italic>X. laevis</italic> myeloperoxidase (mpo)-specific probe (ACD Bio) were used according to manufacturer’s instructions to visualize mpo-positive neutrophils in frog skin tissues.</p>
<p>Towards avidin staining, skin tissues were fixed in 4% paraformaldehyde, washed with saline, cryo-protected in 15% then 30% sucrose, flash-frozen in optimal cutting temperature (OCT) compound (Fisher) and cryo-sectioned onto microscope slides (Fisher). Frozen sections were stained with Texas red-conjugated avidin (ThermoFisher) and DAPI (ThermoFisher) and glass cover slips mounted with Prolong Antifade mounting media (ThermoFisher). Tissues were imaged using a Zeiss LSCM-800 confocal microscope. For each slide, 15 fields of view were enumerated at ×20 (Plan-Apochromat 20×/0.75) objective. Images were inversed in ImageJ to improve contrast and resolution of heparin-positive skin mast cells.</p>
</sec>
<sec id="s8d">
<title>Analyses of immune gene expression and <italic>Bd</italic> skin loads</title>
<p>Cells and tissues were homogenized in Trizol reagent, flash frozen on dry ice, and stored at −80°C until RNA and DNA isolation. RNA isolation was performed using Trizol according to the manufacturer’s directions. RNA-Seq is described in detail below. For qRT-PCR gene expression analysis, RNA (500 ng/sample) was reverse transcribed into cDNA using cDNA qscript supermix (Quantabio, Beverly, MA). Following RNA extraction, back extraction buffer (4 M guanidinethiocyanate, 50 mM sodium citrate, 1 M Tris pH 8.0) was mixed with the remaining Trizol layer and centrifuged to isolate the DNA-containing aqueous phase. DNA was precipitated overnight with isopropanol, pelleted by centrifugation, washed with 80% ethanol, and resuspended in TE buffer (10 mM Tris pH 8.0, 1 mM EDTA). DNA was purified by phenol:chloroform extraction and resuspended in molecular grade water (VWR).</p>
<p>Quantitative gene expression analyses for both <italic>Bd</italic> and <italic>X. laevis</italic> cells and tissues were performed using the CFX96 Real-Time System (Bio-Rad Laboratories, Hercules, CA) and iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories). The Bio-Rad CFX Manager software (SDS) was employed for all expression analysis. All expression analyses were conducted using the ΔΔCt method relative to the <italic>gapdh</italic> endogenous control gene for <italic>X. laevis.</italic> Fungal load quantification was assessed by absolute qPCR. Isolated <italic>Bd</italic> DNA (JEL 197 isolate) was serially diluted and used as the standard curve. Primers were designed and validated against the <italic>Bd</italic> ribosomal RNA internal transcribed spacer 1 (ITS1). The primers used are listed in <xref rid="tbls1" ref-type="table">Table S1</xref>.</p>
</sec>
<sec id="s8e">
<title>Analyses of mucus <italic>Bd</italic>-killing capacities</title>
<p>Mucosomes were collected from mast cell- or vector-enriched <italic>X. laevis</italic> that were either mock- or <italic>Bd</italic>-infected for 10 or 21 days. To this end, individual <italic>X. laevis</italic> were soaked in a 5 mL water bath for 1 hour. Each water sample was then lyophilized, reconstituted with 500 µl of molecular grade water, and passed through a sterile cell strainer to remove large debris.</p>
<p><italic>Bd</italic> was seeded in opaque white 96-well plates (20,000 zoospores in 50 µl of tryptone broth / well). Next, 50 µl of mucosome solution was added to each well (100 µl total well volume) in three replicate wells per individual <italic>X. laevis</italic> mucosome. Mucosomes, tryptone broth, and water were each plated alone as controls. Plates were sealed with parafilm and incubated at 19°C for 16 hrs with gentle mixing (20 rpm).</p>
<p>Zoospore viability was determined with the CellTiter-Glo 2.0 Cell Viability assay kit (Promega) according to the manufacturer’s instructions and using a SpectraMax plate reader (Molecular Devices, San Jose, CA). Luminescence readings were fitted to a standard curve (descending proportions of heat-killed zoospores to viable zoospores) to calculate the number of viable zoospores in each well. Zoospores were heated-killed at 65°C for 15 mins.</p>
</sec>
<sec id="s8f">
<title>Skin microbiome analyses</title>
<p>All analyses were performed in the R environment version 4.0.3 (R Core Team, 2020). Demultiplexed reads were imported from Basespace into R environment for sequence processing. Package “dada2”<sup><xref ref-type="bibr" rid="c71">71</xref></sup> was used to perform quality filtering using their standard filtering parameters (<italic>i.e.</italic>, maxEE = 2), which collapsed high quality reads into amplicon sequence variant (ASV) and removed chimeras. Bacterial taxonomy was assigned using Silva version 138.1. The R package “phyloseq”<sup><xref ref-type="bibr" rid="c72">72</xref></sup> was used to import and merge the final ASV table, taxonomy table, and metadata to create a phyloseq object to perform further analyses. Sequences classified as cyanobacteria/chloroplast and those unclassified at kingdom were removed. Singletons were filtered out (<italic>i.e.</italic>, ASVs with only one sequence read in one individual). The R package “decontam”<sup><xref ref-type="bibr" rid="c73">73</xref></sup> was used to remove potential contaminants using the method “combined.” The ZymoBIOMICS microbial community standards (positive controls) were analyzed, and we found genera in similar relative abundances as described by Zymo.</p>
<p>To determine how <italic>Bd</italic> and mast cell treatments impacted skin microbiomes, the microbiome structure was examined. The components of microbiome structure were: ASV richness (measured as <italic>Bd</italic>-inhibitory ASV richness and total ASV richness), microbial composition (measured by Jaccard and Bray-Curtis distances), and sequence abundance of <italic>Bd</italic>-inhibitory ASVs (measured as individual <italic>Bd</italic>-inhibitory ASV sequence counts and total relative abundance of <italic>Bd</italic>-inhibitory ASVs). To characterize variation in microbiome structure, Mast Cell (mast cell normal and mast cell+), <italic>Bd</italic> (<italic>Bd</italic>- and <italic>Bd</italic>+) and their interaction as explanatory variables at two-time points Day 10 and Day 21 post <italic>Bd</italic> infection were included. For this characterization, log-transformed ASV richness in ANOVAs, microbial composition measures in PERMANOVAs and log-transformed raw sequence counts in ANOVAs (with post-hoc corrections for multiple comparisons) were used. For identification of <italic>Bd</italic>-inhibitory ASVs, methods as described in by Jimenez <italic>et al</italic>., 2022<sup><xref ref-type="bibr" rid="c74">74</xref></sup> were followed.</p>
<p>Days 10 and 21 post <italic>Bd</italic> infection were chose for these analyses, since they represent an intermediate and a later timepoint of infection.</p>
</sec>
</sec>
<sec id="s9">
<table-wrap id="tbls1" orientation="portrait" position="float">
<label>Table S1.</label>
<caption><title>List of primer sequences</title></caption>
<graphic xlink:href="560127v2_tbls1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Figure S1.</label>
<caption><title>Enrichment of neutrophils in frog skins.</title>
<p>Frogs were administered with rCSF3 subcutaneously and their skins examined for specific esterase activity at 0, 6, 12 and 24 hrs post injection. Results are means + SEM of SE-positive cells per field of view from 4 animals per time point (<italic>N</italic>=4). Asterisks indicate significance: p &lt; 0.05 by one-way ANOVA with Tukey post-hoc analysis.</p></caption>
<graphic xlink:href="560127v2_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Figure S2.</label>
<caption><title>Mucosomes from mast cell-enriched frogs do not confer <italic>Bd</italic> killing.</title>
<p>Differences in musocome-killing capacities were determined by incubating zoospores with total mucosome contents for 16 hrs. Mucosomes were acquired from 10- or 21-day mock- or <italic>Bd</italic>-infected <italic>X. laevis</italic> that were injected with rSCF (mast cell-enriched) or r-ctrl (control). Results are mean <underline>+</underline> SEM and were analyzed via a two-way ANOVA; 10- and 21-day experimental groups were analyzed independently; alpha set at 0.05. <italic>N</italic> = 5 experimental animals per treatment group for 10 dpi analyses and <italic>N</italic>= 8 experimental animals per treatment group for 21 dpi analyses.</p></caption>
<graphic xlink:href="560127v2_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Figure S3.</label>
<caption><title>Mast cell enrichment protects frogs from <italic>Bd</italic>-mediated changes to skin microbiomes.</title>
<p>At 21 days post mock or <italic>Bd</italic>-challenge, we examined (<bold>A</bold>) community composition (Jaccard distances shown with 80% confidence ellipses), (<bold>F</bold>) relative abundance of <italic>Bd</italic>-inhibitory bacteria and (<bold>G</bold>) bacterial richness. Letters above bars indicate statistically distinct groups.</p></caption>
<graphic xlink:href="560127v2_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Figure S4.</label>
<caption><title>Expression of antimicrobial peptides in mast cell-enriched, Bd-infected frog skins.</title>
<p>(<bold>A</bold>) <italic>Magainin</italic> (<italic>mag</italic>) and (<bold>B</bold>) <italic>pgla</italic> expression was examined in control and mast cell-enriched frog skins after 12 hrs of enrichment or after 10 or 21 days of mock- or <italic>Bd</italic>-challenge, <italic>N</italic>=6. Asterisks indicate significance: p &lt; 0.05 by one-way ANOVA with Tukey post-hoc analysis.</p></caption>
<graphic xlink:href="560127v2_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Figure S5.</label>
<caption><title>IL4 elicits hallmark gene expression but does not protect Bd-infected frogs.</title>
<p>(<bold>A</bold>) Expression of selected genes in skin following subcutaneous injection of rIL4 (<italic>N</italic>=7). (<bold>B</bold>) Frogs were exposed to <italic>Bd</italic> and 24 hrs later injected subcutaneously with rIL4 or r-ctrl. Skin <italic>Bd</italic> loads were assessed 9 days following injection (<italic>N</italic>=8, per group). Asterisks denote statistical significance, <italic>p</italic> &lt; 0.05 via ANOVA with Tukey post-hoc analysis.</p></caption>
<graphic xlink:href="560127v2_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92168.2.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Brian S</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study reveals the role of skin-resident mast cells in amphibians in mediating antimicrobial responses. The data are <bold>compelling</bold> and highlight species-specific biology that can cross-inform human mast cell biology in a species that does not rely on IgE as a primary mechanism for antimicrobial skin responses.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92168.2.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The global decline of amphibians is primarily attributed to deadly disease outbreaks caused by the chytrid fungus, Batrachochytrium dendrobatidis (Bd). It is unclear whether and how skin-resident immune cells defend against Bd. Although it is well known that mammalian mast cells are crucial immune sentinels in the skin and play a pivotal role in immune recognition of pathogens and orchestrating subsequent immune responses, the roles of amphibian mast cells during Bd infections is largely unknown. The current study developed a novel way to enrich X. laevis skin mast cells by injecting the skin with recombinant stem cell factor (SCF), a KIT ligand required for mast cell differentiation and survival. The investigators found an enrichment of skin mast cells provides X. laevis substantial protection against Bd and mitigates the inflammation-related skin damage resulting from Bd infection. Additionally, the augmentation of mast cells leads to increased mucin content within cutaneous mucus glands and shields frogs from the alterations to their skin microbiomes caused by Bd.</p>
<p>Strengths:</p>
<p>This study underscores the significance of amphibian skin-resident immune cells in defenses against Bd and introduces a novel approach to examining interactions between amphibian hosts and fungal pathogens.</p>
<p>Weaknesses:</p>
<p>The main weakness of the study is lack of functional analysis of X. laevis mast cells. Upon activation, mast cells have the characteristic feature of degranulation to release histamine, serotonin, proteases, cytokines, and chemokines, etc. The study should determine whether X. laevis mast cells can be degranulated by two commonly used mast cell activators IgE and compound 48/80 for IgE-dependent and independent pathway. This can be easily done in vitro. It is also important to assess whether in vivo these mast cells are degranulated upon Bd infection using avidin staining to visualize vesicle releases from mast cells. Figure 3 only showed rSCF injection caused an increase in mast cells in naïve skin. They need to present whether Bd infection can induce mast cell increase and rSCF injection under Bd infection causes a mast cell increase in the skin. In addition, it is unclear how the enrichment of mast cells provides the protection against Bd infection and alternations to skin microbiomes after infection. It is important to determine whether skin mast cell release any contents mentioned above.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92168.2.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this study, Hauser et al investigate the role of amphibian (Xenopus laevis) mast cells in cutaneous immune responses to the ecologically important pathogen Batrachochytrium dendrobatidis (Bd) using novel methods of in vitro differentiation of bone marrow-derived mast cells and in vivo expansion of skin mast cell populations. They find that bone marrow-derived myeloid precursors cultured in the presence of recombinant X. laevis Stem Cell Factor (rSCF) differentiate into cells that display hallmark characteristics of mast cells. They inject their novel (r)SCF reagent in the skin of X. laevis and find that this stimulates expansion of cutaneous mast cell populations in vivo. They then apply this model of cutaneous mast cell expansion in the setting of Bd infection and find that mast cell expansion attenuates skin burden of Bd zoospores and pathologic features including epithelial thickness and improves protective mucus production and transcriptional markers of barrier function. Utilizing their prior expertise with expanding neutrophil populations in X. laevis, the authors compare mast cell expansion using (r)SCF to neutrophil expansion using recombinant colony stimulating factor 3 (rCSF3) and find that neutrophil expansion in Bd infection leads to greater burden of zoospores and worse skin pathology. Combining these two observations, they demonstrate that mast cell expansion using rSCF attenuates cutaneous neutrophilic infiltration. They further show that mast cell expansion correlates to cutaneous IL-4 expression, and that treatment with exogenous rIL-4 reduces neutrophilic infiltration and restores markers of epithelial health, offering a mechanism by which mast cell expansion protects from Bd infection.</p>
<p>Strengths:</p>
<p>The authors report a novel method of expanding amphibian mast cells utilizing their custom-made rSCF reagent. They rigorously characterize expanded mast cells in vitro and in vivo using histologic, morphologic, transcriptional, and functional assays. This establishes solid footing with which to then study the role of rSCF-stimulated mast cell expansion in the Bd infection model. This appears to be the first demonstration of exogenous use of rSCF in amphibians to expand mast cell populations and may set a foundation for future mechanistic studies of mast cells in the X. laevis model organism. Building on prior work, they are able to contrast mast cell expansion with their neutrophil expansion model, allowing them to infer a mechanistic link between mast cell expansion and IL-4 production and subsequent suppression of neutrophil infiltration and cutaneous dysbiosis.</p>
<p>Weaknesses:</p>
<p>The main weaknesses derive from technical limitations inherent to the Xenopus model at this time. For example, in mice a mechanistic study would be expected to use IL-4 knockouts, preferably mast cell-specific, to prove the link between mast cell expansion and IL-4 production being necessary and sufficient to suppress neutrophils. However, the novel reagents in this manuscript present a compelling technical advance and a step forward in the tools available to study amphibian biology.</p>
<p>In addition to their discussion, one open question from the revised manuscript is how a single treatment with rSCF leads to a peak in mast cell numbers and then decline to baseline in mock-infected frogs, while Bd infection either sustains rSCF-boosted mast cells or leads to steady mast cell increase over time in control-treated frogs. Whether this is mediated by endogenous SCF or some other factor remains unexplored.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92168.2.sa0</article-id>
<title-group>
<article-title>None</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hauser</surname>
<given-names>Kelsey A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garvey</surname>
<given-names>Christina N</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Crow</surname>
<given-names>Ryley S</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hossainey</surname>
<given-names>Muhammad RH</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Howard</surname>
<given-names>Dustin T</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ranganathan</surname>
<given-names>Netra</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gentry</surname>
<given-names>Lindsey K</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yaparla</surname>
<given-names>Amulya</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalia</surname>
<given-names>Namarta</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zelle</surname>
<given-names>Mira</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Elizabeth J</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duttargi</surname>
<given-names>Anju N</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rollins-Smith</surname>
<given-names>Louise A</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muletz-Wolz</surname>
<given-names>Carly R</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grayfer</surname>
<given-names>Leon</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Author response:</p>
<p>The following is the authors’ response to the current reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1</bold> <bold>(Public Review):</bold></p>
<p>Summary: The global decline of amphibians is primarily attributed to deadly disease outbreaks caused by the chytrid fungus, Batrachochytrium dendrobatidis (Bd). It is unclear whether and how skin-resident immune cells defend against Bd. Although it is well known that mammalian mast cells are crucial immune sentinels in the skin and play a pivotal role in immune recognition of pathogens and orchestrating subsequent immune responses, the roles of amphibian mast cells during Bd infections is largely unknown. The current study developed a novel way to enrich X. laevis skin mast cells by injecting the skin with recombinant stem cell factor (SCF), a KIT ligand required for mast cell differentiation and survival. The investigators found an enrichment of skin mast cells provides X. laevis substantial protection against Bd and mitigates the inflammation-related skin damage resulting from Bd infection. Additionally, the augmentation of mast cells leads to increased mucin content within cutaneous mucus glands and shields frogs from the alterations to their skin microbiomes caused by Bd.</p>
<p>Strengths: This study underscores the significance of amphibian skin-resident immune cells in defenses against Bd and introduces a novel approach to examining interactions between amphibian hosts and fungal pathogens.</p>
</disp-quote>
<p>We thank the reviewer for recognizing the significance and the novelty of our work.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses: The main weakness of the study is lack of functional analysis of X. laevis mast cells. Upon activation, mast cells have the characteristic feature of degranulation to release histamine, serotonin, proteases, cytokines, and chemokines, etc. The study should determine whether X. laevis mast cells can be degranulated by two commonly used mast cell activators IgE and compound 48/80 for IgE-dependent and independent pathway. This can be easily done in vitro. It is also important to assess whether in vivo these mast cells are degranulated upon Bd infection using avidin staining to visualize vesicle releases from mast cells. Figure 3 only showed rSCF injection caused an increase in mast cells in naïve skin. They need to present whether Bd infection can induce mast cell increase and rSCF injection under Bd infection causes a mast cell increase in the skin. In addition, it is unclear how the enrichment of mast cells provides the protection against Bd infection and alternations to skin microbiomes after infection. It is important to determine whether skin mast cell release any contents mentioned above.</p>
</disp-quote>
<p>We would like to thank the reviewer for taking the time to review our work and providing us with valuable feedback.</p>
<p>Please note, that as indicated in our previous rebuttal to reviewers, amphibians do not possess the IgE antibody isotype1.</p>
<p>To our knowledge, there are no published works describing the approaches used in studying mammalian mast cell degranulation towards examining amphibian mast cells. While there are commercially available kits and reagents for examining mammalian mast cell granule content, most of these do not cross-react with amphibian counterparts. This is especially true of cytokines and chemokines, which diverged quickly with evolution and thus do not share substantial protein sequence identity across species as diverged as frogs and mammals. We would also like to highlight the fact that several studies suggest that amphibian mast cells lack histamine2, 3, 4, 5 and serotonin2, 6. While following up on these findings would be possible, we would like to respectfully emphasize that adopting approaches used in mammalian research to comparative immunology work is not always straightforward.</p>
<p>As we highlight in our manuscript, frog mast cells upregulate their expression of interleukin-4 (IL4), a hallmark cytokine associated with mammalian mast cells7. The additional findings presented in our revised manuscript indicate that mast cells respond to Bd by upregulating IL4 expression in vitro and in vivo. Together, this suggests that IL4 may be a central means by which frog mast cells confer protection against Bd, by counteracting Bd-elicited inflammation, including minimizing neutrophil infiltration, maintaining skin integrity, and promoting cutaneous mucus production. Please find that these additional results are presented in Figure 8 and are described in the results and discussion sections of our revised manuscript.</p>
<p>Our attempts to elicit degranulation of frog mast cells using compound 48/80 have so far not been successful. This may reflect technical issues with assays optimized for mammalian mast cells or biological difference between frog and mammalian mast cells, such as species differences in mas-related G-protein coupled receptors, through which compound 48/80 acts8. We will continue to explore means to study frog mast cell degranulation both in vitro and in vivo but also respectfully point out that while degranulation is a feature commonly associated with mammalian mast cells, this is not the only means by which the mammalian mast cells confer their immunological effects. Indeed, our studies suggest that frog mast cell IL4 production may be a key means by which these cells offer anti-Bd protection.</p>
<p>Please note that we successfully adopted an avidin staining approach to visualize mast cell heparin content in vitro and to evaluate cutaneous mast cell numbers in vivo in control and mast cell-enriched, mock- and Bd-infected animals. This additional work is depicted in Figure 4 and addressed in the results and discussion sections of our revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary: In this study, Hauser et al investigate the role of amphibian (Xenopus laevis) mast cells in cutaneous immune responses to the ecologically important pathogen Batrachochytrium dendrobatidis (Bd) using novel methods of in vitro differentiation of bone marrow-derived mast cells and in vivo expansion of skin mast cell populations. They find that bone marrow-derived myeloid precursors cultured in the presence of recombinant X. laevis Stem Cell Factor (rSCF) differentiate into cells that display hallmark characteristics of mast cells. They inject their novel (r)SCF reagent in the skin of X. laevis and find that this stimulates expansion of cutaneous mast cell populations in vivo. They then apply this model of cutaneous mast cell expansion in the setting of Bd infection and find that mast cell expansion attenuates skin burden of Bd zoospores and pathologic features including epithelial thickness and improves protective mucus production and transcriptional markers of barrier function. Utilizing their prior expertise with expanding neutrophil populations in X. laevis, the authors compare mast cell expansion using (r)SCF to neutrophil expansion using recombinant colony stimulating factor 3 (rCSF3) and find that neutrophil expansion in Bd infection leads to greater burden of zoospores and worse skin pathology. Combining these two observations, they demonstrate that mast cell expansion using rSCF attenuates cutaneous neutrophilic infiltration. They further show that mast cell expansion correlates to cutaneous IL-4 expression, and that treatment with exogenous rIL-4 reduces neutrophilic infiltration and restores markers of epithelial health, offering a mechanism by which mast cell expansion protects from Bd infection.</p>
<p>Strengths: The authors report a novel method of expanding amphibian mast cells utilizing their custom-made rSCF reagent. They rigorously characterize expanded mast cells in vitro and in vivo using histologic, morphologic, transcriptional, and functional assays. This establishes solid footing with which to then study the role of rSCF-stimulated mast cell expansion in the Bd infection model. This appears to be the first demonstration of exogenous use of rSCF in amphibians to expand mast cell populations and may set a foundation for future mechanistic studies of mast cells in the X. laevis model organism. Building on prior work, they are able to contrast mast cell expansion with their neutrophil expansion model, allowing them to infer a mechanistic link between mast cell expansion and IL-4 production and subsequent suppression of neutrophil infiltration and cutaneous dysbiosis.</p>
</disp-quote>
<p>We thank the reviewer for recognizing the rigorousness and utility of the studies presented in our manuscript.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses: The main weaknesses derive from technical limitations inherent to the Xenopus model at this time. For example, in mice a mechanistic study would be expected to use IL-4 knockouts, preferably mast cell-specific, to prove the link between mast cell expansion and IL-4 production being necessary and sufficient to suppress neutrophils. However, the novel reagents in this manuscript present a compelling technical advance and a step forward in the tools available to study amphibian biology.</p>
</disp-quote>
<p>We agree with the reviewer that an IL4 knock-out animal model would be a great way to support our findings. Unfortunately, working with a non-mammalian model such as X. laevis poses limitations that include lack of knock-out lines for immunology research. Moreover, as mentioned in our manuscript, we do not believe that IL4 is the sole mast cell-produced component responsible for the conferred antifungal protection. We thank the reviewer for acknowledging the limitations of our model system and recognizing the novelty, technical advances, and merits of the work presented in our manuscript.</p>
<disp-quote content-type="editor-comment">
<p>In addition to their discussion, one open question from the revised manuscript is how a single treatment with rSCF leads to a peak in mast cell numbers and then decline to baseline in mock-infected frogs, while Bd infection either sustains rSCF-boosted mast cells or leads to steady mast cell increase over time in control-treated frogs. Whether this is mediated by endogenous SCF or some other factor remains unexplored.</p>
</disp-quote>
<p>This is an interesting question that we hope to explore in future studies. We did not see significant differences in skin SCF gene expression at 21 days post Bd infection. This does not rule out the possibility that the observed Bd-mediated effects to frog skin mast cell composition are not due to changes in skin SCF gene expression at earlier infection times, alone or in combination with other host or pathogen derived factors. We know that other factors are responsible for homing/retention of antimicrobial and immunosuppressive granulocyte subsets within frog skin9 and we postulate that some of these may be distinct mast cell types. Additionally, Bd is known to produce a myriad of immunomodulatory factors10, which may well also directly affect frog skin mast cell composition. Mammalian mast cells are heterogenous and are homed or recruited into tissues by an extensive array of host as well as microbiome-derived components11, 12. Undoubtedly, the frog skin mast cell composition is likewise complex, dynamic, and contingent on a plethora of host, cutaneous microbial flora- and in this case also Bd-produced factors.</p>
<p>References</p>
<p>(1) Flajnik, M.F. A cold-blooded view of adaptive immunity. Nat Rev Immunol 18, 438-453 (2018).</p>
<p>(2) Mulero, I., Sepulcre, M.P., Meseguer, J., Garcia-Ayala, A. &amp; Mulero, V. Histamine is stored in mast cells of most evolutionarily advanced fish and regulates the fish inflammatory response. Proc Natl Acad Sci U S A 104, 19434-19439 (2007).</p>
<p>(3) Reite, O.B. A phylogenetical approach to the functional significance of tissue mast cell histamine. Nature 206, 1334-1336 (1965).</p>
<p>(4) Reite, O.B. Comparative physiology of histamine. Physiol Rev 52, 778-819 (1972).</p>
<p>(5) Takaya, K., Fujita, T. &amp; Endo, K. Mast cells free of histamine in Rana catasbiana. Nature 215, 776-777 (1967).</p>
<p>(6) Galli, S.J. New insights into &quot;the riddle of the mast cells&quot;: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62, 5-33 (1990).</p>
<p>(7) Babina, M., Guhl, S., Artuc, M. &amp; Zuberbier, T. IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure. Archives of dermatological research 308, 665-670 (2016).</p>
<p>(8) Hermans, M.A.W. et al. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2. Front Immunol 12, 625284 (2021).</p>
<p>(9) Hauser, K. et al. Discovery of granulocyte-lineage cells in the skin of the amphibian Xenopus laevis. FACETS 5, 571 (2020).</p>
<p>(10) Rollins-Smith, L.A. &amp; Le Sage, E.H. Batrachochytrium fungi: stealth invaders in amphibian skin. Curr Opin Microbiol 61, 124-132 (2021).</p>
<p>(11) Halova, I., Draberova, L. &amp; Draber, P. Mast cell chemotaxis - chemoattractants and signaling pathways. Front Immunol 3, 119 (2012).</p>
<p>(12) West, P.W. &amp; Bulfone-Paus, S. Mast cell tissue heterogeneity and specificity of immune cell recruitment. Front Immunol 13, 932090 (2022).</p>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>Summary:</p>
<p>The global decline of amphibians is primarily attributed to deadly disease outbreaks caused by the chytrid fungus, Batrachochytrium dendrobatidis (Bd). It is unclear whether and how skin-resident immune cells defend against Bd. Although it is well known that mammalian mast cells are crucial immune sentinels in the skin and play a pivotal role in the immune recognition of pathogens and orchestrating subsequent immune responses, the roles of amphibian mast cells during Bd infections are largely unknown. The current study developed a novel way to enrich X. laevis skin mast cells by injecting the skin with recombinant stem cell factor (SCF), a KIT ligand required for mast cell differentiation and survival. The investigators found an enrichment of skin mast cells provides X. laevis substantial protection against Bd and mitigates the inflammation-related skin damage resulting from Bd infection. Additionally, the augmentation of mast cells leads to increased mucin content within cutaneous mucus glands and shields frogs from the alterations to their skin microbiomes caused by Bd.</p>
<p>Strengths:</p>
<p>This study underscores the significance of amphibian skin-resident immune cells in defenses against Bd and introduces a novel approach to examining interactions between amphibian hosts and fungal pathogens.</p>
</disp-quote>
<p>We thank the reviewer for acknowledging the novelty and importance of the work presented in our manuscript.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>The main weakness of the study is the lack of functional analysis of X. laevis mast cells. Upon activation, mast cells have the characteristic feature of degranulation to release histamine, serotonin, proteases, cytokines, and chemokines, etc. The study should determine whether X. laevis mast cells can be degranulated by two commonly used mast cell activators IgE and compound 48/80 for IgE-dependent and independent pathways. This can be easily done in vitro. It is also important to assess whether in vivo these mast cells are degranulated upon Bd infection using avidin staining to visualize vesicle releases from mast cells. Figure 3 only showed rSCF injection caused an increase in mast cells in naïve skin. They need to present whether Bd infection can induce mast cell increase and rSCF injection under Bd infection causes a mast cell increase in the skin. In addition, it is unclear how the enrichment of mast cells provides protection against Bd infection and alternations to skin microbiomes after infection. It is important to determine whether skin mast cells release any contents mentioned above.</p>
</disp-quote>
<p>We would like to thank the reviewer for taking the time to review our work and providing us with valuable feedback. We feel that we have successfully incorporated the reviewer’s suggestions into our revised manuscript, thereby improving this work.</p>
<p>Please note that amphibians do not possess the IgE antibody isotype1.</p>
<p>To our knowledge there have been no published work assimilating approaches used when studying mammalian mast cell degranulation towards examining amphibian mast cells. While there are commercially available kits and reagents for examining mammalian mast cell granule content, most of these reagents do not cross-react with amphibian counterparts. This is especially true of cytokines and chemokines, which diverged quickly with evolution and thus do not share substantial protein sequence identity across species as diverged as frogs and mammals. Additionally, several studies suggest that amphibian mast cells lack histamine2, 3, 4, 5 and serotonin2, 6. Respectfully, while following up on these findings is possible, we would not consider adopting approaches used in mammalian research to comparative immunology work as easy.</p>
<p>As noted in our manuscript, frog mast cells upregulate their expression of interleukin-4 (IL4), which is a hallmark cytokine associated with mammalian mast cells7. The additional findings, presented in our revised manuscript indicate that mast cells respond to Bd by upregulating IL4 expression in vitro and in vivo. In turn, our work indicates that IL4 may be a central means by which frog mast cells confer protection against Bd, by counteracting Bd-elicited inflammation, including minimizing neutrophil infiltration, maintaining skin integrity, and promoting mucus production by skin mucus glands. Please find that these additional findings are presented in Figure 8 of our revised manuscript and are described in the results and discussion sections of the paper.</p>
<p>Our attempts to elicit degranulation of frog mast cells using compound 48/80 have so far not been successful. This may reflect technical issues with assays optimized for mammalian mast cells or biological difference between frog and mammalian mast cells, such as species differences in mas-related G-protein coupled receptors, through which compound 48/80 acts8. We will continue explore means to study frog mast cell degranulation both in vitro and in vivo but would also like to respectfully point out that while mast cell degranulation is a feature most associated with mammalian mast cells, this is not the only means by which the mammalian mast cells confer their immunological effects. Indeed, our additional studies suggest that mast cell IL4 production may be a key means by which these cells offer anti-Bd protection.</p>
<p>Please find that we have adopted an avidin-staining approach to visualize mast cell heparin content in vitro and to evaluate mast cell numbers in vivo in the skins of control and mast cell-enriched, mock- and Bd-infected animals. This additional work is depicted in Figure 4 of our revised manuscript and addressed in the results and discussion sections of our revised paper.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>In this study, Hauser et al investigate the role of amphibian (Xenopus laevis) mast cells in cutaneous immune responses to the ecologically important pathogen Batrachochytrium dendrobatidis (Bd) using novel methods of in vitro differentiation of bone marrow-derived mast cells and in vivo expansion of skin mast cell populations. They find that bone marrow-derived myeloid precursors cultured in the presence of recombinant X. laevis Stem Cell Factor (rSCF) differentiate into cells that display hallmark characteristics of mast cells. They inject their novel (r)SCF reagent into the skin of X. laevis and find that this stimulates the expansion of cutaneous mast cell populations in vivo. They then apply this model of cutaneous mast cell expansion in the setting of Bd infection and find that mast cell expansion attenuates the skin burden of Bd zoospores and pathologic features including epithelial thickness and improves protective mucus production and transcriptional markers of barrier function. Utilizing their prior expertise with expanding neutrophil populations in X. laevis, the authors compare mast cell expansion using (r)SCF to neutrophil expansion using recombinant colony-stimulating factor 3 (rCSF3) and find that neutrophil expansion in Bd infection leads to greater burden of zoospores and worse skin pathology.</p>
<p>Strengths:</p>
<p>The authors report a novel method of expanding amphibian mast cells utilizing their custom-made rSCF reagent. They rigorously characterize expanded mast cells in vitro and in vivo using histologic, morphologic, transcriptional, and functional assays. This establishes solid footing with which to then study the role of rSCF-stimulated mast cell expansion in the Bd infection model. This appears to be the first demonstration of the exogenous use of rSCF in amphibians to expand mast cell populations and may set a foundation for future mechanistic studies of mast cells in the X. laevis model organism.</p>
</disp-quote>
<p>We thank the reviewer for recognizing the breadth and extent of the undertaking that culminated in this manuscript. Indeed, this manuscript would not have been possible without considerable reagent development and adaptation of techniques that had previously not been used for amphibian immunity research. In line with the reviewer’s sentiment, to our knowledge this is the first report of using molecular approaches to augment amphibian mast cells, which we hope will pave the way for new areas of research within the fields of comparative immunology and amphibian disease biology.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>The conclusions regarding the role of mast cell expansion in controlling Bd infection would be stronger with a more rigorous evaluation of the model, as there are some key gaps and remaining questions regarding the data. For example:</p>
<p>(1) Granulocyte expansion is carefully quantified in the initial time courses of rSCF and rCSF3 injections, but similar quantification is not provided in the disease models (Figures 3E, 4G, 5D-G). A key implication of the opposing effects of mast cell vs neutrophil expansion is that mast cells may suppress neutrophil recruitment or function. Alternatively, mast cells also express notable levels of csfr3 (Figure 2) and previous work from this group (Hauser et al, Facets 2020) showed rG-CSF-stimulated peritoneal granulocytes express mast cell markers including kit and tpsab1, raising the question of what effect rCSF3 might have on mast cell populations in the skin. Considering these points, it would be helpful if both mast cells and neutrophils were quantified histologically (based on Figure 1, they can be readily distinguished by SE or Giemsa stain) in the Bd infection models.</p>
</disp-quote>
<p>We thank the reviewer for this insightful suggestion. Please find that we successfully adopted an in situ hybridization approach to evaluate neutrophil numbers in the skins of control and mast cell-enriched, mock- and Bd-infected animals based on expression of the neutrophil marker, myeloperoxidase (MPO9).  Please find these results are presented in Figures 6 and 8 of our revised manuscript and addressed in the appropriate sections of our revised paper.</p>
<p>Our findings suggest that rSCF administration results in the accumulation of mast cells that are polarized such, that they ablate the inflammatory response elicited by Bd infection, such as through mechanisms like IL4 production. Mammalian mast cells, including peritonea-resident mast cells, express csf3r10, 11. For this reason, we used MPO expression to visualize neutrophil skin infiltration in Figures 6 and 8 of our revised work. While the X. laevis animal model does not permit nearly the degree of immune cell resolution afforded by mammalian animal models, we do know that the adult X. laevis peritonea contain a myriad of immune cell subsets. We anticipate that the high kit expression reported by Hauser et al., 2020 in the rCSF3-recruited peritoneal leukocytes reflects the presence of mast cells therein.</p>
<p>Please find that we have used avidin-staining and MPO in situ hybridization to respectively visualize and enumerate mast cells and neutrophils in the skin of control and mast cell-enriched, mock- and Bd-infected animals. Indeed, our results show interesting, experimental condition-dependent changes in both the skin neutrophil and mast cell numbers. The results of these additional studies are presented in Figures 4, 6 and 8 of the revised manuscript and addressed in the results and discussions sections of our revised paper.</p>
<disp-quote content-type="editor-comment">
<p>(2) Epithelial thickness and inflammation in Bd infection are reported to be reduced by rSCF treatment (Figure 3E, 5A-B) or increased by rCSF3 treatment (Figure 4G) but quantification of these critical readouts is not shown.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. We scored epithelial thickness under the distinct conditions described in our manuscript and presented the quantified data in Figures 5 and 8 of the revised paper.</p>
<disp-quote content-type="editor-comment">
<p>(3) Critical time points in the Bd model are incompletely characterized. Mast cell expansion decreases zoospore burden at 21 dpi, while there is no difference at 7 dpi (Figure 3E). Conversely, neutrophil expansion increases zoospore burden at 7 dpi, but no corresponding 21 dpi data is shown for comparison (Figure 4G). Microbiota analysis is performed at a third time point,10 dpi (Figure 5D-G), making it difficult to compare with the data from the 7 dpi and 21 dpi time points. Reporting consistent readouts at these three time points is important to draw solid conclusions about the relationship of mast cell expansion to Bd infection and shifts in microbiota.</p>
</disp-quote>
<p>We thank reviewer for noting this discrepancy. Please find that we have repeated our mast cell-enrichment, Bd-challenge studies, examining days 10 and 21 post infection. Our new findings indicate that compared to control animals, mast cell-enrichment does result in significant reduction in Bd loads at both 10 and 21 dpi. The difference in Bd loads between r-ctrl and rSCF-treated animals at 10 dpi corroborates the other parameters that are altered between the two treatment groups at this experimental time point.</p>
<p>Our question regarding the roles of inflammatory granulocytes/neutrophils during Bd infections was that of ‘how’ rather ‘when’ these cells affect Bd infections.  Thus, and because the central focus of this work was mast cells and not other granulocyte subsets; when we saw that rCSF3-recruited granulocytes adversely affect Bd infections at 7 days, we did not pursue the kinetics of these observations further. We plan to explore the roles of inflammatory mediators and immune cell subsets during the course of Bd infections but feel that these future studies are more peripheral to the central thesis of the present manuscript regarding the roles of frog mast cells during Bd infections.</p>
<disp-quote content-type="editor-comment">
<p>(4) Although the effect of rSCF treatment on Bd zoospores is significant at 21 dpi (Figure 3E), bacterial microbiota changes at 21 dpi are not (Figure S3B-C). This discrepancy, how it relates to the bacterial microbiota changes at 10 dpi, and why 7, 10, and 21 dpi time points were chosen for these different readouts (Figure 5F-G), is not discussed.</p>
</disp-quote>
<p>Please find that our additional studies indicate that compared to control animals, frog skin mast cell-enrichment results in significant reduction in Bd loads at 10 dpi. This corroborate our other findings including the observation that at 10 dpi, control animals exhibit reduced microbial richness whereas mast cell-enriched frogs were protected from this disruption of their microbiome. The amphibian microbiome serves as a major barrier to these fungal infections12 and we anticipate that Bd-mediated disruption of microbial richness facilitates host skin colonization by this pathogen. In turn, we anticipate that frog mast cells are conferring the observed anti-Bd protection in part by preventing microbial disassembly and thus interfering with optimal Bd colonization and growth on frog skins. Please find that we acknowledge and discuss these notions in our revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(5) The time course of rSCF or rCSF3 treatments relative to Bd infection in the experiments is not clear. Were the treatments given 12 hours prior to the final analysis point to maximize the effect? For example, in Figure 3E, were rSCF injections given at 6.5 dpi and 20.5 dpi? Or were treatments administered on day 0 of the infection model? If the latter, how do the authors explain the effects at 7 dpi or 21 dpi given mast cell and neutrophil numbers return to baseline within 24 hours after rSCF or rCSF3 treatment, respectively?</p>
</disp-quote>
<p>Please find that in our revised manuscript, we underlined the kinetics of our animal treatments and Bd-infections. In brief, for mast cell-enrichment, animals were injected with r-ctrl or rSCF, challenged 12 hours later with Bd and examined after 10 (per reviewers’ suggestions) and 21 days of infection. For neutrophil enrichment, animals were injected with r-ctrl or rCSF3, challenged 12 hours later with Bd and examined after 7 days of infection.</p>
<disp-quote content-type="editor-comment">
<p>The title of the manuscript may be mildly overstated. Although Bd infection can indeed be deadly, mortality was not a readout in this study, and it is not clear from the data reported that expanding skin mast cells would ultimately prevent progression to death in Bd infections.</p>
</disp-quote>
<p>We acknowledge this point. The revised manuscript will be titled: “Amphibian mast cells: barriers to chytrid fungus infections”.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public Review):</bold></p>
<p>Summary:</p>
<p>Hauser et al. provide an exceptional study describing the role of resident mast cells in amphibian epidermis that produce anti-inflammatory cytokines that prevent Batrachochytrium dendrobatidis (Bd) infection from causing harmful inflammation, and also protect frogs from changes in skin microbiomes and loss of mucin in glands and loss of mucus integrity that otherwise cause changes to their skin microbiomes. Neutrophils, in contrast, were not protective against Bd infection. Beyond the beautiful cytology and transcriptional profiling, the authors utilized elegant cell enrichment experiments to enrich mast cells by recombinant stem cell factor, or to enrich neutrophils by recombinant colony-stimulating factor-3, and examined respective infection outcomes in Xenopus.</p>
<p>Strengths:</p>
<p>Through the use of recombinant IL4, the authors were able to test and eliminate the hypothesis that mast cell production of IL4 was the mechanism of host protection from Bd infection. Instead, impacts on the mucus glands and interaction with the skin microbiome are implicated as the protective mechanism. These results will press disease ecologists to examine the relative importance of this immune defense among species, the influence of mast cells on the skin microbiome and mucosal function, and open the potential for modulating mucosal defense.</p>
</disp-quote>
<p>We thank the reviewer for recognizing the utility of the work presented in our manuscript.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>A reduction of bacterial diversity upon infection, as described at the end of the results section, may not always be an &quot;adverse effect,&quot; particularly given that anti-Bd function of the microbiome increased. Some authors (see Letourneau et al. 2022 ISME, or Woodhams et al. 2023 DCI) consider these short-term alterations as encoding ecological memory, such that continued exposure to a pathogen would encounter an enriched microbial defense. Regardless, mast cell-initiated protection of the mucus layer may negate the need for this microbial memory defense.</p>
</disp-quote>
<p>We thank the reviewer their insightful comment. We have revised our discussion to include this notion.</p>
<disp-quote content-type="editor-comment">
<p>While the description of the mast cell location in the epidermal skin layer in amphibians is novel, it is not known how representative these results are across species ranging in chytridiomycosis susceptibility. No management applications are provided such as methods to increase this defense without the use of recombinant stem cell factor, and more discussion is needed on how the mast cell component (abundance, distribution in the skin) of the epidermis develops or is regulated.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. Please find that we have added a paragraph to our revised manuscripts to address possible source(s) of skin mast cells and a statement acknowledging that greater understanding of mast cell biology across distinct amphibian species may be used to develop future strategies for management of amphibian diseases.</p>
<p>We are very thankful to the reviewer for this excellent suggestion but would like to point out that the work presented in our manuscript was driven by comparative immunology questions more than by conservation biology. As such and considering just how little is known about mast cells outside of mammals; we chose not to speculate too much into possible utilities of altering amphibian skin mast cell composition and instead to focus our discussion on the immediate takeaways of the work presented by our paper.</p>
<p><bold>References</bold></p>
<p>(1) Flajnik, M.F. A cold-blooded view of adaptive immunity. Nat Rev Immunol 18, 438-453 (2018).</p>
<p>(2) Mulero, I., Sepulcre, M.P., Meseguer, J., Garcia-Ayala, A. &amp; Mulero, V. Histamine is stored in mast cells of most evolutionarily advanced fish and regulates the fish inflammatory response. Proc Natl Acad Sci U S A 104, 19434-19439 (2007).</p>
<p>(3) Reite, O.B. A phylogenetical approach to the functional significance of tissue mast cell histamine. Nature 206, 1334-1336 (1965).</p>
<p>(4) Reite, O.B. Comparative physiology of histamine. Physiol Rev 52, 778-819 (1972).</p>
<p>(5) Takaya, K., Fujita, T. &amp; Endo, K. Mast cells free of histamine in Rana catasbiana. Nature 215, 776-777 (1967).</p>
<p>(6) Galli, S.J. New insights into &quot;the riddle of the mast cells&quot;: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62, 5-33 (1990).</p>
<p>(7) Babina, M., Guhl, S., Artuc, M. &amp; Zuberbier, T. IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure. Archives of dermatological research 308, 665-670 (2016).</p>
<p>(8) Hermans, M.A.W. et al. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2. Front Immunol 12, 625284 (2021).</p>
<p>(9) Buchan, K.D. et al. A transgenic zebrafish line for in vivo visualisation of neutrophil myeloperoxidase. PLoS One 14, e0215592 (2019).</p>
<p>(10) Aponte-Lopez, A., Enciso, J., Munoz-Cruz, S. &amp; Fuentes-Panana, E.M. An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses. Int J Mol Sci 21 (2020).</p>
<p>(11) Jamur, M.C. et al. Mast cell repopulation of the peritoneal cavity: contribution of mast cell progenitors versus bone marrow derived committed mast cell precursors. BMC Immunol 11, 32 (2010).</p>
<p>(12) Walke, J.B. &amp; Belden, L.K. Harnessing the Microbiome to Prevent Fungal Infections: Lessons from Amphibians. PLoS Pathog 12, e1005796 (2016).</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2: (Recommendations For The Authors):</bold></p>
</disp-quote>
<p>We thank the reviewer for their excellent suggestions, their time reviewing this work and their help with this manuscript.</p>
<p>While we were not able to incorporate some of these changes, please find that we have significantly altered our manuscript in accordance with the reviewer’s suggestions from their public review. We feel that we have substantially altered our paper, including providing considerable additional data, supporting the key findings therein.</p>
<disp-quote content-type="editor-comment">
<p>(1) The heatmap in Figure 1I appears to be scaled data, similar to Figure 4A, in which case the indicated scale numbers are not correct (e.g. they should be -2 to 2, or -3 to 3)</p>
</disp-quote>
<p>Thank you for the suggestion. Please find that we have changed this figure accordingly.</p>
<disp-quote content-type="editor-comment">
<p>(2) For Figure 1, additional curated gene lists might better illustrate the difference in cell types, e.g. include the data for a panel of mast cell genes in a heatmap (mcpt1, tpsab1, etc.) and another panel of curated neutrophil genes (e.g. lyz) in a heatmap. If the authors still have leftover RNA, qPCR verification of some of the critical genes (e.g. kit) would add to the rigor of the analysis, as this study is the foundation of a new method for culturing amphibian mast cells.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. Unfortunately, we do not have leftover RNA/cDNA and we have not been able to locate mcpt1 or tpsab1 in our DEGs. We anticipate that this issue may stem from the suboptimal annotation of the Xenopus laevis genome. We agree that curating more mast cell/neutrophil genes would be ideal but feel that we have adequately highlighted those genes that are differentially expressed between the two populations in our analysis.</p>
<disp-quote content-type="editor-comment">
<p>(3) The presentation of counts in Figure 2 is a bit hard to interpret. Although it is mentioned that everything is statistically significant, explicitly showing statistics for each gene would be better. One possibility would be to use a volcano plot (p-value vs log2 fold change) and highlight the genes shown in Figure 2, potentially with an accompanying heat map to show replicate variability.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. We entertained presenting the data as volcano plots or heat maps, but in the end felt that the bar graphs better conveyed the information that we are hoping to get across. Please note that the error bars in the bar graph depict the replicate variability. Please also note that to highlight that all the depicted genes were differentially expressed, we italicized the statement in the corresponding figure legend: “All depicted genes were significantly differentially expressed between the two populations”.</p>
<disp-quote content-type="editor-comment">
<p>(4) Narratively, it might make more sense to put Figure 4A-C with Figure 3.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. Please find that we significantly revised most of our figures to better convey the content therein. We combined the content of Figure 4A-C with Figure 5A-C and added data on epidermal thickness under different conditions into this figure; Figure 5 of our revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>(5) If possible, complementing the skin RNA-seq from rSCF treatment in Bd infection with skin RNA-seq from rCSF3 treatment to compare effects on transcriptional programs of barrier function, etc would elevate this study and add additional insights into cutaneous inflammation in the setting of Bd infection.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion. We anticipate that the skin inflammation caused by Bd infection is not due solely to neutrophil infiltration and artificially altering the frog skin neutrophil content would thus not recapitulate chytridiomycosis progression. We completely agree that it would be valuable to examine barrier functions in control and mast cell-enriched, Bd-infected frogs. This is something that we hope to pursue further in future studies but feel that together with our additional findings, we are presenting a significant amount of data to constitute a stand-alone story.</p>
<disp-quote content-type="editor-comment">
<p>(6) In Figure S1A, analyzing only 3 AMP genes by qPCR is perhaps too focused. As a control, it would be useful to also test some genes known to be functionally important in neutrophil anti-microbial responses, e.g. lyz. Expanding on this experiment by performing RNA-seq on Bd-treated, bone-marrow-derived mast cells and neutrophils would be a great addition to the manuscript and an important resource for future studies in the field. The fact that the use of rSCF (or rCSF3) enables the differentiation of these cells in large numbers of pure populations presents this unique opportunity. Although IL-4 did not end up affecting mucus production, clues to the mediator(s) of this mast cell-dependent effect may be found with unbiased RNA-seq after exposure to Bd.</p>
</disp-quote>
<p>We thank the reviewer for this suggestion but would like to point out that our manuscript is focused on mast cells rather than neutrophils. We also believe that in vitro exposure of leukocytes to Bd is not the most physiologically relevant model of what would happen to skin-resident and incoming immune cell subsets, since Bd primarily infects top-most keratinocytes. We anticipate that rather than coming into direct contact with the fungus, cells like mast cells and neutrophils are responding to Bd-produced and infected cell-produced products. For this reason, we did not perform RNA-seq analysis of in vitro derived mast cells or neutrophils stimulated with Bd. As we develop more X. laevis-specific reagents, we hope to revisit the question of infected skin mast cell and neutrophil gene expression profiles but are not in a position to ask these questions at this time.</p>
<p>This work is also guided by a finite budget, and we feel that together with our significant additional findings described in our revised manuscript, we are presenting a substantial amount of work to constitute a stand-alone story and manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p>
<p>The following are minor edits needed in the text and figure legends:</p>
<p>Standardize terms such as IL4 instead of il4 or ril4 vs rIL4 throughout. Also, r-SCF vs rSCF.</p>
</disp-quote>
<p>Thank you. Please find that we have standardized such terms throughout our revised manuscript. Please note that we are adhering to the convention that gene names are in lower case, protein names are in upper case and recombinant protein names are preceded by an ‘r’.</p>
<disp-quote content-type="editor-comment">
<p>Pg 9 Change &quot;In contract&quot; to &quot;In contrast&quot;.</p>
</disp-quote>
<p>Thank you and changed accordingly.</p>
<disp-quote content-type="editor-comment">
<p>Fig 4 - Perhaps indicate if results in addition to 7dpi are also available.</p>
</disp-quote>
<p>Please find that we analyzed Bd loads in control and mast cell-enriched, infected frogs after 10 dpi. This data is presented in Figures 3 and 4 of our revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>Similarly in Fig. 5, are results other than 10dpi available in the supplement?</p>
</disp-quote>
<p>Please find that the results from the microbiome studies are presented in supplemental figure 3 (Fig. S3). Please note that the results presented in original manuscript Fig. 5A-C - revised manuscript Fig. 5B-E depict data for 21 dpi, which is the longest examined infection timepoint. We present data from 1 and 10 dpi in Fig. 4 of our revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>Indicate why these days were chosen in the methods.</p>
</disp-quote>
<p>Please find that we indicated why the experimental timepoints were chosen, in the methods section of our revised manuscript.</p>
<disp-quote content-type="editor-comment">
<p>Fig S1 legend has errors in describing which panels are for which asterisks.</p>
<p>Fig. S3 legend indicates panels F and G.</p>
</disp-quote>
<p>Thank you. Please find that we revised our supplemental figures and amended the corresponding figure legends.</p>
</body>
</sub-article>
</article>